UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)


☒			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, ~~2020~~2021


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 1-35229

Xylem Inc.

(Exact name of registrant as specified in its charter)


Indiana						45-2080495
(State or other jurisdiction of incorporation or organization)						(I.R.S. Employer Identification No.)

1 International Drive, Rye Brook, NY 10573

(Address of principal executive offices) (Zip code)

(914) 323-5700

(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange of which registered

Common Stock, par value $0.01 per share

XYL

New York Stock Exchange

2.250% Senior Notes due 2023

XYL23

New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit ~~and post~~ such files). Yes ☑ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☑

Accelerated filer

☐

Non-accelerated filer

☐

Smaller reporting company

☐

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☑

As of ~~May 1, 2020,~~April 30, 2021, there were ~~179,915,293~~180,041,590 outstanding shares of the registrant’s common stock, par value $0.01 per share.

Xylem Inc.

Table of Contents


ITEM			PAGE
PART I – Financial Information
Item 1	-	~~Condensed Consolidated~~ Financial Statements:
		Condensed Consolidated Income Statements for the Three Months Ended March 31 3 1 , 20202 201 and ~~201~~20 920 (Unaudited)	3
		Condensed Consolidated Statements of Comprehensive Income for the Three Months Ended March ~~31,~~ ~~2020~~3 1 , 202 1 and ~~201~~20 920 (Unaudited)	4
		Condensed Consolidated Balance Sheets as of ~~March~~Mar ch 3 1 , ~~2020~~202 1 and December 31, ~~201~~20 920 (Unaudited)	5
		Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 3 1 , 20202 201 and ~~201~~20 920 (Unaudited)	6
		Notes to the Condensed Consolidated Financial Statements (Unaudited)	7
Item 2	-	Management’s Discussion and Analysis of Financial Condition and Results of Operations	28
Item 3	-	Quantitative and Qualitative Disclosures About Market Risk	4443
Item 4	-	Controls and Procedures	4443
PART II – Other Information
Item 1	-	Legal Proceedings	4544
Item 1A	-	Risk Factors	4544
Item 2	-	Unregistered Sales of Equity Securities and Use of Proceeds	4644
Item 3	-	Defaults Upon Senior Securities	4644
Item 4	-	Mine Safety Disclosures	4644
Item 5	-	Other Information	4644
Item 6	-	Exhibits	4644
		Signatures	4847

PART I

ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

XYLEM INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED INCOME STATEMENTS (Unaudited)

(in millions, except per share data)


For the three months ended March 31,	For the three months ended March 31,	2020		2019		For the three months ended March 31,	2021		2020
Revenue	Revenue	$	1,123	$	1,237	Revenue	$	1,256	$	1,123
Cost of revenue	Cost of revenue	714		763		Cost of revenue	766		714
Gross profit	Gross profit	409		474		Gross profit	490		409
Selling, general and administrative expenses	Selling, general and administrative expenses	297		303		Selling, general and administrative expenses	301		297
Research and development expenses	Research and development expenses	49		51		Research and development expenses	50		49
Restructuring and asset impairment charges	Restructuring and asset impairment charges	2		11		Restructuring and asset impairment charges	6		2

Operating income	Operating income	61		109		Operating income	133		61
Interest expense	Interest expense	16		18		Interest expense	21		16
Other non-operating (expense) income, net		(3)		2
Gain from sale of business		—		1
Other non-operating income (expense), net						Other non-operating income (expense), net	2		(3)

Income before taxes	Income before taxes	42		94		Income before taxes	114		42
Income tax expense	Income tax expense	4		15		Income tax expense	27		4
Net income	Net income	$	38	$	79	Net income	$	87	$	38

Earnings per share:	Earnings per share:					Earnings per share:
Basic	Basic	$	0.21	$	0.44	Basic	$	0.49	$	0.21
Diluted	Diluted	$	0.21	$	0.43	Diluted	$	0.48	$	0.21
Weighted average number of shares:	Weighted average number of shares:					Weighted average number of shares:
Basic	Basic	180.2		179.7		Basic	180.3		180.2
Diluted	Diluted	181.3		181.1		Diluted	181.5		181.3

See accompanying notes to condensed consolidated financial statements.

XYLEM INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) ~~INCOME~~ (Unaudited)

(in millions)


For the three months ended March 31,	For the three months ended March 31,	2020		2019		For the three months ended March 31,	2021		2020
Net income	Net income	$	38	$	79	Net income	$	87	$	38
Other comprehensive (loss) income, before tax:
Other comprehensive income (loss), before tax:						Other comprehensive income (loss), before tax:
Foreign currency translation adjustment	Foreign currency translation adjustment	(78)		29		Foreign currency translation adjustment	10		(78)

Net change in derivative hedge agreements:	Net change in derivative hedge agreements:					Net change in derivative hedge agreements:
Unrealized loss	Unrealized loss	(2)		(9)		Unrealized loss	(11)		(2)
Amount of loss reclassified into net income		3		2
Net change in postretirement benefit plans:
Amount of (gain) loss reclassified into net income						Amount of (gain) loss reclassified into net income	(3)		3
Net change in post-retirement benefit plans:						Net change in post-retirement benefit plans:

Amortization of prior service credit	Amortization of prior service credit	(1)		(1)		Amortization of prior service credit	(1)		(1)
Amortization of net actuarial loss into net income	Amortization of net actuarial loss into net income	5		3		Amortization of net actuarial loss into net income	6		5

Other comprehensive (loss) income, before tax		(73)		24
Income tax expense related to items of other comprehensive (loss) income		14		4
Other comprehensive (loss) income, net of tax		(87)		20
Comprehensive (loss) income		$	(49)	$	99
Other comprehensive income (loss), before tax						Other comprehensive income (loss), before tax	1		(73)
Income tax expense related to items of other comprehensive income (loss)						Income tax expense related to items of other comprehensive income (loss)	14		14
Other comprehensive loss, net of tax						Other comprehensive loss, net of tax	(13)		(87)
Comprehensive income (loss)						Comprehensive income (loss)	$	74	$	(49)
Less: comprehensive loss attributable to noncontrolling interests	Less: comprehensive loss attributable to noncontrolling interests	(1)		—		Less: comprehensive loss attributable to noncontrolling interests	0		(1)
Comprehensive (loss) income attributable to Xylem		$	(48)	$	99
Comprehensive income (loss) attributable to Xylem						Comprehensive income (loss) attributable to Xylem	$	74	$	(48)

See accompanying notes to condensed consolidated financial statements.

XYLEM INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

(in millions, except per share amounts)

March 31,
2020 December 31,
2019

ASSETS
Current assets:
Cash and cash equivalents $ 739 $ 724
Receivables, less allowances for discounts, returns and doubtful accounts of $29 and $35 in 2020 and 2019, respectively 975 1,036
Inventories 573 539
Prepaid and other current assets 175 151
Total current assets 2,462 2,450
Property, plant and equipment, net 628 658
Goodwill 2,790 2,839
Other intangible assets, net 1,141 1,174
Other non-current assets 570 589
Total assets $ 7,591 $ 7,710
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable $ 506 $ 597
Accrued and other current liabilities 619 628
Short-term borrowings and current maturities of long-term debt 459 276
Total current liabilities 1,584 1,501
Long-term debt 2,031 2,040
Accrued postretirement benefits 433 445
Deferred income tax liabilities 315 310
Other non-current accrued liabilities 407 447
Total liabilities 4,770 4,743
Commitments and contingencies (Note 18)
Stockholders’ equity:
Common Stock – par value $0.01 per share:
Authorized 750.0 shares, issued 194.4 shares and 193.9 shares in 2020 and 2019, respectively 2 2
Capital in excess of par value 2,004 1,991
Retained earnings 1,854 1,866
Treasury stock – at cost 14.5 shares and 13.7 shares in 2020 and 2019, respectively (587) (527)
Accumulated other comprehensive loss (461) (375)
Total stockholders’ equity 2,812 2,957
Non-controlling interests 9 10
Total equity 2,821 2,967
Total liabilities and stockholders’ equity $ 7,591 $ 7,710


	March 31, 2021		December 31, 2020

ASSETS
Current assets:
Cash and cash equivalents	$	1,688	$	1,875

Receivables, less allowances for discounts, returns and credit losses of $38 and $46 in 2021 and 2020, respectively	952		923
Inventories	596		558
Prepaid and other current assets	165		167

Total current assets	3,401		3,523
Property, plant and equipment, net	627		657
Goodwill	2,831		2,854
Other intangible assets, net	1,075		1,093
Other non-current assets	611		623
Total assets	$	8,545	$	8,750
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	530	$	569
Accrued and other current liabilities	714		787
Short-term borrowings and current maturities of long-term debt	600		600
Total current liabilities	1,844		1,956
Long-term debt	2,460		2,484
Accrued post-retirement benefits	502		519
Deferred income tax liabilities	257		242
Other non-current accrued liabilities	536		573
Total liabilities	5,599		5,774
Commitments and contingencies (Note 16)	0		0
Stockholders’ equity:
Common Stock – par value $0.01 per share:
Authorized 750.0 shares, issued 195.2 shares and 194.9 shares in 2021 and 2020, respectively	2		2
Capital in excess of par value	2,049		2,037
Retained earnings	1,967		1,930
Treasury stock – at cost 15.2 shares and 14.5 shares in 2021 and 2020, respectively	(655)		(588)
Accumulated other comprehensive loss	(426)		(413)
Total stockholders’ equity	2,937		2,968
Non-controlling interests	9		8
Total equity	2,946		2,976
Total liabilities and stockholders’ equity	$	8,545	$	8,750

See accompanying notes to condensed consolidated financial statements.

XYLEM INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

(in millions)


For the three months ended March 31,	For the three months ended March 31,	2020		2019		For the three months ended March 31,	2021		2020
Operating Activities	Operating Activities					Operating Activities
Net income	Net income	$	38	$	79	Net income	$	87	$	38
Adjustments to reconcile net income to net cash provided by operating activities:
Adjustments to reconcile net income to net cash used by operating activities:						Adjustments to reconcile net income to net cash used by operating activities:
Depreciation	Depreciation	29		29		Depreciation	30		29
Amortization	Amortization	35		35		Amortization	32		35
Share-based compensation	Share-based compensation	8		9		Share-based compensation	9		8
Restructuring and asset impairment charges	Restructuring and asset impairment charges	2		11		Restructuring and asset impairment charges	6		2

Gain from sale of business		—		(1)

Other, net	Other, net	4		1		Other, net	2		4
Payments for restructuring	Payments for restructuring	(8)		(4)		Payments for restructuring	(12)		(8)
Changes in assets and liabilities (net of acquisitions):	Changes in assets and liabilities (net of acquisitions):					Changes in assets and liabilities (net of acquisitions):
Changes in receivables	Changes in receivables	23		7		Changes in receivables	(42)		23
Changes in inventories	Changes in inventories	(54)		(25)		Changes in inventories	(46)		(54)
Changes in accounts payable	Changes in accounts payable	(68)		(17)		Changes in accounts payable	(29)		(68)

Other, net	Other, net	(11)		(41)		Other, net	(63)		(11)
Net Cash – Operating activities	Net Cash – Operating activities	(2)		83		Net Cash – Operating activities	(26)		(2)
Investing Activities	Investing Activities					Investing Activities
Capital expenditures	Capital expenditures	(51)		(69)		Capital expenditures	(39)		(51)
Acquisitions of businesses, net of cash acquired		—		(5)

Proceeds from the sale of property, plant and equipment						Proceeds from the sale of property, plant and equipment	1		0

Other, net	Other, net	3		(3)		Other, net	7		3
Net Cash – Investing activities	Net Cash – Investing activities	(48)		(77)		Net Cash – Investing activities	(31)		(48)
Financing Activities	Financing Activities					Financing Activities
Short-term debt issued, net	Short-term debt issued, net	193		50		Short-term debt issued, net	0		193
Short-term debt repaid	Short-term debt repaid	(3)		—		Short-term debt repaid	0		(3)

Repurchase of common stock	Repurchase of common stock	(60)		(39)		Repurchase of common stock	(67)		(60)
Proceeds from exercise of employee stock options	Proceeds from exercise of employee stock options	5		4		Proceeds from exercise of employee stock options	3		5
Dividends paid	Dividends paid	(48)		(44)		Dividends paid	(51)		(48)

Net Cash – Financing activities	Net Cash – Financing activities	87		(29)		Net Cash – Financing activities	(115)		87
Effect of exchange rate changes on cash	Effect of exchange rate changes on cash	(22)		2		Effect of exchange rate changes on cash	(15)		(22)
Net change in cash and cash equivalents	Net change in cash and cash equivalents	15		(21)		Net change in cash and cash equivalents	(187)		15
Cash and cash equivalents at beginning of year	Cash and cash equivalents at beginning of year	724		296		Cash and cash equivalents at beginning of year	1,875		724
Cash and cash equivalents at end of period	Cash and cash equivalents at end of period	$	739	$	275	Cash and cash equivalents at end of period	$	1,688	$	739
Supplemental disclosure of cash flow information:	Supplemental disclosure of cash flow information:					Supplemental disclosure of cash flow information:
Cash paid during the period for:	Cash paid during the period for:					Cash paid during the period for:
Interest	Interest	$	12	$	13	Interest	$	41	$	12
Income taxes (net of refunds received)	Income taxes (net of refunds received)	$	8	$	18	Income taxes (net of refunds received)	$	28	$	8

See accompanying notes to condensed consolidated financial statements.

XYLEM INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 1. Background and Basis of Presentation

Background

Xylem Inc. (“Xylem” or the “Company”) is a leading equipment and service provider for water and wastewater applications with a broad portfolio of products and services addressing the full cycle of water, from collection, distribution and use to the return of water to the environment.

Xylem operates in 3 segments, Water Infrastructure, Applied Water and Measurement & Control Solutions. See Note ~~19,~~17, "Segment Information", to the condensed consolidated financial statements for further segment background information.

Except as otherwise indicated or unless the context otherwise requires, "Xylem," "we," "us," "our" and the "Company" refer to Xylem Inc. and its subsidiaries.

Basis of Presentation

The interim condensed consolidated financial statements reflect our financial position and results of operations in conformity with accounting principles generally accepted in the United States of America ("GAAP"). All intercompany transactions between our businesses have been eliminated.

The unaudited interim condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") and, in the opinion of management, reflect all adjustments (which include normal recurring adjustments) considered necessary for a fair statement of the financial position and results of operations for the periods presented. Certain information and note disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such SEC rules. We believe that the disclosures made are adequate to make the information presented not misleading. We consistently applied the accounting policies described in our Annual Report on Form 10-K for the year ended December 31, ~~2019~~2020 ("~~2019~~2020 Annual Report") in preparing these unaudited condensed consolidated financial ~~statements, with the exception of accounting standard updates described in Note 2.~~statements. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the notes included in our ~~2019~~2020 Annual Report.

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period. Estimates are revised as additional information becomes available. Estimates and assumptions are used for, but not limited to, ~~postretirement~~post-retirement obligations and assets, revenue recognition, income ~~tax contingency accruals and~~taxes, valuation ~~allowances,~~of intangible assets, goodwill and ~~indefinite lived~~indefinite-lived intangible impairment testing and contingent ~~liabilities~~liabilities. Actual results could differ from these estimates. The global outbreak of the novel coronavirus ("COVID-19") disease in March 2020, declared a pandemic by the World Health Organization, has created significant global volatility, uncertainty and ~~lease accounting.~~economic disruption. The COVID-19 pandemic also has caused increased uncertainty in estimates and assumptions affecting the condensed consolidated financial statements. Actual results could differ from these estimates.

Our quarterly financial periods end on the Saturday closest to the last day of the calendar quarter, except for the fourth quarter which ends on December 31. For ease of presentation, the condensed consolidated financial statements included herein are described as ending on the last day of the calendar quarter.

~~Note 2. Recently Issued Accounting Pronouncements~~

~~Recently Adopted Pronouncements~~

In June 2016, the FASB issued ASU 2016-13, "Financial Instruments-Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments," amending the accounting for the impairment of financial instruments, including trade receivables. Under previous guidance, credit losses were recognized when the applicable losses had a probable likelihood of occurring and this assessment was based on past events and current conditions. The amended current guidance eliminates the “probable” threshold and requires an entity to use a broader range of information, including forecast information when estimating expected credit losses. Generally, this should result in a more timely recognition of credit losses. This guidance is effective for interim and annual periods beginning after December 15, 2019 with early adoption permitted for interim and annual periods beginning after December 15, 2018. The requirements of the amended guidance should be applied using a modified retrospective approach

except for debt securities, which require a prospective transition approach. We adopted this guidance as of January 1, 2020. The adoption of this guidance did not have a material impact on our financial condition and results of operations.

Note ~~3. Acquisitions and Divestitures~~

~~Acquisitions~~

~~During the three months ended March 31, 2020 and 2019 we spent approximately $0 million and $5 million, net of cash received on acquisition activity, respectively.~~

~~Note 4.~~2. Revenue

Disaggregation of Revenue

The following table illustrates the sources of revenue:


		Three Months Ended							Three Months Ended
		March 31,							March 31,
(in millions)	(in millions)	2020		2019		(in millions)	2021		2020
Revenue from contracts with customers	Revenue from contracts with customers	$	1,074	$	1,178	Revenue from contracts with customers	$	1,211	$	1,074
Lease Revenue	Lease Revenue	49		59		Lease Revenue	45		49
Total	Total	$	1,123	$	1,237	Total	$	1,256	$	1,123

The following table reflects revenue from contracts with customers by ~~application:~~application. The table below also reflects updates to the aggregation of applications to simplify and focus presentation.


		Three Months Ended							Three Months Ended
		March 31,							March 31,
(in millions)	(in millions)	2020		2019		(in millions)	2021		2020
Water Infrastructure	Water Infrastructure					Water Infrastructure
Transport	Transport	$	318	$	346	Transport	$	370	$	318
Treatment	Treatment	71		77		Treatment	94		71

Applied Water	Applied Water					Applied Water
Building Services		187		213
Commercial Building Services						Commercial Building Services	147		137
Residential Building Services						Residential Building Services	67		50
Industrial Water	Industrial Water	151		166		Industrial Water	179		151

Measurement & Control Solutions	Measurement & Control Solutions					Measurement & Control Solutions
Water	Water	183		199		Water	283		265
Energy	Energy	72		73		Energy	71		82
Software as a Service		21		24
Test		71		80

Total	Total	$	1,074	$	1,178	Total	$	1,211	$	1,074

The following table reflects revenue from contracts with customers by geographical ~~region:~~region. The presentation of geographic regions below has been updated to better align to how management currently focuses on revenue and growth platforms by geographic region. There has been no change to the Company's reportable segments.


		Three Months Ended							Three Months Ended
		March 31,							March 31,
(in millions)	(in millions)	2020		2019		(in millions)	2021		2020
Water Infrastructure	Water Infrastructure					Water Infrastructure
United States	United States	$	121	$	133	United States	$	123	$	121
Europe		157		160
Asia Pacific		59		74
Western Europe						Western Europe	173		142
Emerging Markets (a)						Emerging Markets (a)	122		86
Other	Other	52		56		Other	46		40

Applied Water	Applied Water					Applied Water
United States	United States	191		201		United States	194		191
Europe		82		94
Asia Pacific		24		39
Western Europe						Western Europe	92		74
Emerging Markets (a)						Emerging Markets (a)	78		50
Other	Other	41		45		Other	29		23

Measurement & Control Solutions	Measurement & Control Solutions					Measurement & Control Solutions
United States	United States	221		236		United States	213		221
Europe		74		72
Asia Pacific		22		31
Western Europe						Western Europe	74		63
Emerging Markets (a)						Emerging Markets (a)	46		41
Other	Other	30		37		Other	21		22

Total	Total	$	1,074	$	1,178	Total	$	1,211	$	1,074

(a)Emerging Markets revenue includes results from the following regions: Eastern Europe, the Middle East and Africa, Latin America and Asia Pacific (excluding Japan, Australia and New Zealand, which are presented in "Other")

Contract Balances

We receive payments from customers based on a billing schedule as established in our contracts. Contract assets relate to costs incurred to perform in advance of scheduled billings. Contract liabilities relate to payments received in advance of performance under the contracts. Changes in contract assets and liabilities are due to our performance under the contract.

The table below provides contract assets, contract liabilities, and significant changes in contract assets and liabilities:


(in millions)	(in millions)	Contract Assets (a)		Contract Liabilities		(in millions)	Contract Assets (a)		Contract Liabilities
Balance at January 1, 2019		$	96	$	113
Additions, net		39		46
Revenue recognized from opening balance		—		(45)
Billings		(32)		—

Other		11		2
Balance at March 31, 2019		$	114	$	116

Balance at January 1, 2020	Balance at January 1, 2020	$	106	$	135	Balance at January 1, 2020	$	106	$	135
Additions, net	Additions, net	42		54		Additions, net	42		54
Revenue recognized from opening balance	Revenue recognized from opening balance	—		(47)		Revenue recognized from opening balance	—		(47)
Billings		(38)		—
Billings transferred to accounts receivable						Billings transferred to accounts receivable	(38)		—

Other	Other	(4)		(4)		Other	(4)		(4)
Balance at March 31, 2020	Balance at March 31, 2020	$	106	$	138	Balance at March 31, 2020	$	106	$	138

Balance at January 1, 2021						Balance at January 1, 2021	$	117	$	166
Additions, net						Additions, net	43		67
Revenue recognized from opening balance						Revenue recognized from opening balance	—		(71)
Billings transferred to accounts receivable						Billings transferred to accounts receivable	(50)		—

Other						Other	(1)		0
Balance at March 31, 2021						Balance at March 31, 2021	$	109	$	162

(a)Excludes receivable balances which are disclosed on the balance sheet

Performance obligations

Delivery schedules vary from customer to customer based upon their requirements. Typically, large projects require longer lead production cycles and delays can occur from time to time. As of March 31, ~~2020,~~2021, the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied or partially unsatisfied for contracts with performance obligations, amount to ~~$380~~$428 million. We expect to recognize the majority of revenue upon the completion of satisfying these performance obligations in the following 60 months. The Company elects to apply the practical expedient to exclude from this disclosure revenue related to performance obligations that are part of a contract whose original expected duration is less than one year.

Note 5.3. Restructuring and Asset Impairment Charges

~~Restructuring~~

From time to time, the Company will incur costs related to restructuring actions in order to optimize our cost base and more strategically position ourselves. During the three months ended March 31, 2021, we recognized restructuring charges of $5 million, of which $4 million relates to actions previously announced in 2020. These charges included reduction of headcount across all segments and asset impairments within our Measurement & Control Solutions segment. During the three months ended March 31, 2020, we recognized restructuring charges of $2 million. ~~We incurred these charges primarily~~

In response to the changes in business and economic conditions arising as a ~~continuation~~result of the COVID-19 pandemic, in June 2020 management committed to a restructuring plan that includes actions across our ~~efforts~~businesses and functions globally. The plan is designed to ~~reposition~~support our ~~European~~long-term financial resilience and ~~North American businesses to optimize~~simplify our ~~cost structure~~operations, strengthen our competitive positioning and ~~improve~~better serve our ~~operational efficiency and effectiveness. The charges included the reduction of headcount within our Water Infrastructure segment.~~customers.

During the three months ended March 31, 2019, we recognized restructuring charges of $8 million. We incurred these charges primarily as a continuation of our efforts to reposition our European and North American businesses to optimize our cost structure and improve our operational efficiency and effectiveness. The charges included the reduction of headcount and consolidation of facilities within our Measurement & Control Solutions and Water Infrastructure segments, as well as headcount reductions within our Applied Water segment.

The following table presents the components of restructuring expense and asset impairment charges:

Three Months Ended
March 31,
(in millions) 2020 2019
By component:
Severance and other charges $ 2 $ 7
Lease related charges — 1
Total restructuring charges $ 2 $ 8
Asset impairment — 3
Total restructuring and asset impairment charges $ 2 $ 11
By segment:
Water Infrastructure $ 2 $ 4
Applied Water — —
Measurement & Control Solutions — 7


	Three Months Ended
	March 31,
(in millions)	2021		2020
By component:
Severance and other charges	$	4	$	2

Asset impairment	1		0


Total restructuring charges	$	5	$	2
Asset impairment charges	1		0
Total restructuring and asset impairment charges	$	6	$	2

By segment:
Water Infrastructure	$	4	$	2
Applied Water	1		0
Measurement & Control Solutions	1		0

The following table displays a roll-forward of the restructuring accruals, presented on our Condensed Consolidated Balance Sheets within ~~"accrued~~"Accrued and other current liabilities" and ~~"other~~"Other non-current accrued liabilities", for the three months ended March 31, ~~2020~~2021 and ~~2019:~~2020:


(in millions)	(in millions)	2020		2019		(in millions)	2021		2020
Restructuring accruals - January 1	Restructuring accruals - January 1	$	27	$	5	Restructuring accruals - January 1	$	29	$	27
Restructuring charges	Restructuring charges	2		8		Restructuring charges	5		2
Cash payments	Cash payments	(8)		(4)		Cash payments	(12)		(8)
Asset impairment						Asset impairment	(1)		0
Foreign currency and other	Foreign currency and other	(1)		—		Foreign currency and other	0		(1)
Restructuring accruals - March 31	Restructuring accruals - March 31	$	20	$	9	Restructuring accruals - March 31	$	21	$	20

By segment:	By segment:					By segment:
Water Infrastructure	Water Infrastructure	$	1	$	2	Water Infrastructure	$	2	$	1
Applied Water	Applied Water	1		—		Applied Water	1		1
Measurement & Control Solutions	Measurement & Control Solutions	17		4		Measurement & Control Solutions	14		17
Regional selling locations (a)	Regional selling locations (a)	1		3		Regional selling locations (a)	4		1

(a)Regional selling locations consist primarily of selling and marketing organizations and related support services that incurred restructuring expense which was allocated to the segments. The liabilities associated with restructuring expense were not allocated to the segments.

The following table presents expected restructuring spend ~~for actions commenced as of March 31, 2020:~~in 2021 and thereafter:

(in millions) Water Infrastructure Applied Water Measurement & Control Solutions Total
Actions Commenced in 2020:
Total expected costs $ 1 $ — $ — $ 1
Costs incurred during Q1 2020 1 — — 1
Total expected costs remaining $ — $ — $ — $ —
Actions Commenced in 2019:
Total expected costs $ 20 $ 5 $ 27 $ 52
Costs incurred during 2019 18 5 27 50
Costs incurred during Q1 2020 1 — — 1
Total expected costs remaining $ 1 $ — $ — $ 1
Actions Commenced in 2017:
Total expected costs $ 12 $ 7 $ 4 $ 23
Costs incurred during 2017 5 4 2 11
Costs incurred during 2018 2 1 1 4
Costs incurred during 2019 1 — 1 2
Costs incurred during Q1 2020 — — — —
Total expected costs remaining $ 4 $ 2 $ — $ 6


(in millions)	Water Infrastructure		Applied Water		Measurement & Control Solutions		Corporate		Total
Actions Commenced in 2021:
Total expected costs	$	3	$	0	$	0	$	0	$	3
Costs incurred during Q1 2021	1		0		0		0		1


Total expected costs remaining	$	2	$	0	$	0	$	0	$	2

Actions Commenced in 2020:
Total expected costs	$	25	$	8	$	33	$	2	$	68
Costs incurred during 2020	19		4		30		0		53
Costs incurred during Q1 2021	2		1		1		0		4


Total expected costs remaining	$	4	$	3	$	2	$	2	$	11

~~The Water Infrastructure actions commenced in 2020 consist primarily of severance charges and are substantially complete.~~ The Water Infrastructure, Applied Water, and Measurement & Control Solutions actions commenced in ~~2019~~2020 consist primarily of severance charges across segments and asset impairment charges in our Measurement & Control Solutions segment. These actions are expected to continue through 2021.

The Water Infrastructure actions commenced in 2021 consist primarily of severance charges. ~~The Applied Water and Measurement & Control Solutions actions are complete and the Water Infrastructure~~These actions are expected to continue through the ~~fourth~~third quarter of 2020. The Water Infrastructure, Applied Water and Measurement & Control Solutions actions commenced in 2017 consist primarily of severance charges. The Measurement & Control Solutions actions are complete and the Water Infrastructure and Applied Water actions are expected to continue through 2021.

~~Asset Impairment~~

During the first quarter of 2019 we determined that certain assets within our Measurement & Control Solutions segment, including a customer relationship, were impaired. Accordingly we recognized an impairment charge of $3 million. Refer to Note 9, "Goodwill and Other Intangible Assets," for additional information.

Note 6.4. Income Taxes

Our quarterly provision for income taxes is measured using an estimated annual effective tax rate, adjusted for discrete items within periods presented. The comparison of our effective tax rate between periods is significantly impacted by the level and mix of earnings and losses by tax jurisdiction and discrete items.

The income tax provision for the three months ended March 31, ~~2020~~2021 was $4$27 million resulting in an effective tax rate of ~~10.0%~~23.3%, compared to a ~~$15~~$4 million ~~charge~~expense resulting in an effective tax rate of ~~16.6%~~10.0% for the same period in ~~2019.~~2020. The effective tax rate for the three month period ended March 31, ~~2020 differs from~~2021 was higher than the ~~United States~~U.S. federal statutory rate primarily due to tax settlements and the ~~mix of earnings in jurisdictions,~~Global Intangible Low Taxed Income ("GILTI") inclusion, partially offset by ~~the Global Intangible Low-Taxed Income ("GILTI") inclusion.~~favorable earnings mix. Additionally, the effective tax rate for the three month period ended March 31, ~~2020 is lower than~~2021 differs from the same period in ~~2019~~2020 due to the ~~relative~~ impact of the tax settlements in the current period, partially offset by the benefit from favorable equity compensation deductions onin the ~~effective tax rate.~~prior year.

Unrecognized Tax Benefits

We recognize tax benefits from uncertain tax positions only if it is more likely than not that ~~the~~a tax position will be sustained on examination by ~~the~~ taxing authorities or upon completion of the litigation process, based on the technical merits of the position. The

tax benefits recognized in the condensed consolidated financial statements from such positions are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate resolution. The amount of unrecognized tax benefits at March 31, ~~2020~~2021 was ~~$128~~$113 million, as compared to ~~$129~~$114 million at December 31, ~~2019,~~2020, which if ultimately recognized will reduce our effective tax rate. We do not believe ~~that~~ it is reasonably possible that the unrecognized tax benefits will ~~be reduced by approximately $4 million~~significantly change within the next ~~12 months as a result of the expiration of certain statutes of limitations.~~twelve months. We classify interest expense relating to unrecognized tax benefits as a component of ~~other~~"Other non-operating ~~expense, net,~~(expense) income, net" and tax penalties as a component of ~~income~~"Income tax ~~expense~~expense" in our Condensed Consolidated Income Statements. As of March 31, ~~2020,~~2021, we had $9$8 million of interest accrued for unrecognized tax benefits.

During 2019, Xylem’s Swedish subsidiary received a tax assessment for the 2013 tax year related to the tax treatment of an intercompany transfer of certain intellectual property that was made in connection with a reorganization of our European businesses. The assessment asserts an aggregate amount of approximately $80 million for tax, penalties and interest. Xylem filed an appeal with the Administrative Court of Stockholm. Management, in consultation with external legal advisors, believes it is more likely than not that Xylem will prevail on the proposed assessment and is vigorously defending our position through litigation. As of March 31, ~~2020,~~2021, we have not recorded any unrecognized tax benefits related to this uncertain tax position.

Note 7.5. Earnings Per Share

The following is a reconciliation of the shares used in calculating basic and diluted net earnings per share:


		Three Months Ended							Three Months Ended
		March 31,							March 31,
		2020		2019			2021		2020
Net income (in millions)	Net income (in millions)	$	38	$	79	Net income (in millions)	$	87	$	38
Shares (in thousands):	Shares (in thousands):					Shares (in thousands):
Weighted average common shares outstanding	Weighted average common shares outstanding	180,154		179,720		Weighted average common shares outstanding	180,252		180,154
Add: Participating securities (a)	Add: Participating securities (a)	25		26		Add: Participating securities (a)	15		25
Weighted average common shares outstanding — Basic	Weighted average common shares outstanding — Basic	180,179		179,746		Weighted average common shares outstanding — Basic	180,267		180,179
Plus incremental shares from assumed conversions: (b)	Plus incremental shares from assumed conversions: (b)					Plus incremental shares from assumed conversions: (b)
Dilutive effect of stock options	Dilutive effect of stock options	725		835		Dilutive effect of stock options	794		725
Dilutive effect of restricted stock units and performance share units	Dilutive effect of restricted stock units and performance share units	390		532		Dilutive effect of restricted stock units and performance share units	413		390

Weighted average common shares outstanding — Diluted	Weighted average common shares outstanding — Diluted	181,294		181,113		Weighted average common shares outstanding — Diluted	181,474		181,294
Basic earnings per share	Basic earnings per share	$	0.21	$	0.44	Basic earnings per share	$	0.49	$	0.21
Diluted earnings per share	Diluted earnings per share	$	0.21	$	0.43	Diluted earnings per share	$	0.48	$	0.21

(a)Restricted stock unit awards containing rights to non-forfeitable dividends that participate in undistributed earnings with common shareholders are considered participating securities for purposes of computing earnings per share.

(b)Incremental shares from stock options, restricted stock units and performance share units are computed by the treasury stock method. The weighted average shares listed below were not included in the computation of diluted earnings per share because to do so would have been anti-dilutive for the periods presented or were otherwise excluded under the treasury stock method. The treasury stock method calculates dilution assuming the exercise of all in-the-money options and vesting of restricted stock units and performance share units, reduced by the repurchase of shares with the proceeds from the assumed exercises and unrecognized compensation expense for outstanding awards. Performance share units will be included in the treasury stock calculation of diluted earnings per share upon achievement of underlying performance or market conditions at the end of the reporting period. See Note ~~15,~~13, "Share-Based Compensation Plans", to the condensed consolidated financial statements for further detail on the performance share units.


		Three Months Ended				Three Months Ended
		March 31,				March 31,
(in thousands)	(in thousands)	2020	2019	(in thousands)	2021	2020
Stock options	Stock options	1,367	1,394	Stock options	1,249	1,367
Restricted stock units	Restricted stock units	314	348	Restricted stock units	285	314
Performance share units	Performance share units	285	472	Performance share units	352	285

Note 8.6. Inventories

The components of total inventories are summarized as follows:


(in millions)	(in millions)	March 31, 2020		December 31, 2019		(in millions)	March 31, 2021		December 31, 2020
Finished goods	Finished goods	$	228	$	212	Finished goods	$	232	$	221
Work in process	Work in process	51		47		Work in process	58		49
Raw materials	Raw materials	294		280		Raw materials	306		288
Total inventories	Total inventories	$	573	$	539	Total inventories	$	596	$	558

Note 9.7. Goodwill and Other Intangible Assets

Goodwill

Changes in the carrying value of goodwill by reportable segment for the three months ended March 31, ~~2020~~2021 are as follows:

(in millions)
Water
Infrastructure
Applied Water Measurement & Control Solutions Total
Balance as of January 1, 2020 $ 651 $ 513 $ 1,675 $ 2,839
Activity in 2020
Foreign currency and other (13) (5) (31) (49)
Balance as of March 31, 2020 $ 638 $ 508 $ 1,644 $ 2,790


(in millions)	Water Infrastructure		Applied Water		Measurement & Control Solutions		Total
Balance as of January 1, 2021	$	668	$	529	$	1,657	$	2,854
Activity in 2021


Foreign currency and other	(6)		(3)		(14)		(23)
Balance as of March 31, 2021	$	662	$	526	$	1,643	$	2,831

As of March 31, 2021, goodwill included accumulated impairment loss of $206 million within the Measurement & Control Solutions segment.

Other Intangible Assets

Information regarding our other intangible assets is as follows:


		March 31, 2020										December 31, 2019											March 31, 2021				December 31, 2020
(in millions)	(in millions)	Carrying Amount		Accumulated Amortization		Net Intangibles		Carrying Amount		Accumulated Amortization		Net Intangibles		(in millions)	Carrying Amount		Accumulated Amortization		Net Intangibles		Carrying Amount		Accumulated Amortization		Net Intangibles
Customer and distributor relationships	Customer and distributor relationships	$	931	$	(361)	$	570	$	945	$	(352)	$	593	Customer and distributor relationships	$	939	$	(421)	$	518	$	941	$	(410)	$	531
Proprietary technology and patents	Proprietary technology and patents	200		(113)		87		204		(111)		93		Proprietary technology and patents	205		(134)		71		206		(131)		75
Trademarks	Trademarks	145		(54)		91		148		(52)		96		Trademarks	143		(65)		78		143		(63)		80
Software	Software	442		(215)		227		428		(206)		222		Software	510		(274)		236		500		(265)		235
Other	Other	17		(16)		1		20		(16)		4		Other	21		(18)		3		21		(18)		3
Indefinite-lived intangibles	Indefinite-lived intangibles	165		—		165		166		—		166		Indefinite-lived intangibles	169		0		169		169		0		169
Other Intangibles	Other Intangibles	$	1,900	$	(759)	$	1,141	$	1,911	$	(737)	$	1,174	Other Intangibles	$	1,987	$	(912)	$	1,075	$	1,980	$	(887)	$	1,093

Amortization expense related to finite-lived intangible assets was ~~$35~~$32 million and $35 million for the three month periods ended March 31, 2021 and 2020, ~~and 2019,~~ respectively.

During the first quarter of 2019, we determined that the intended use of a finite-lived customer relationship within the test application of our Measurement & Control Solutions segment had changed. Accordingly we recorded a $3

~~million impairment charge. The charge was calculated using the income approach and is reflected in “Restructuring and asset impairment charges” in our Condensed Consolidated Income Statements.~~

Note ~~10.~~8. Derivative Financial Instruments

Risk Management Objective of Using Derivatives

We are exposed to certain risks arising from both our business operations and economic conditions, and we principally manage our exposures to these risks through management of our core business activities. Certain of our foreign operations expose us to fluctuations of foreign interest rates and exchange rates that may impact revenue, expenses, cash receipts, cash payments, and the value of our stockholders' equity. We enter into derivative financial instruments to protect the value or fix the amount of certain cash flows in terms of the functional currency of the business unit with that exposure and reduce the volatility in stockholders' equity.

Cash Flow Hedges of Foreign Exchange Risk

We are exposed to fluctuations in various foreign currencies against our functional currencies. We use foreign currency derivatives, including currency forward agreements, to manage our exposure to fluctuations in the various exchange rates. Currency forward agreements involve fixing the foreign currency exchange rate for delivery of a specified amount of foreign currency on a specified date.

Certain business units with exposure to foreign currency exchange risks have designated certain currency forward agreements as cash flow hedges of forecasted intercompany inventory purchases and sales. Our principal currency exposures relate to the Euro, Swedish Krona, British Pound, Canadian Dollar, Polish Zloty and Australian Dollar. We had foreign exchange contracts with purchased notional amounts totaling ~~$376~~$400 million and $0

$0 million as of March 31, ~~2020~~2021 and December 31, ~~2019,~~2020, respectively. As of March 31, ~~2020,~~2021, our most significant foreign currency derivatives included contracts to sell U.S. Dollar and purchase Euro, purchase Swedish Krona and sell Euro, sell British Pound and purchase Euro, purchase Polish Zloty and sell Euro, purchase U.S. Dollar and sell Canadian Dollar, and to sell Canadian Dollar and purchase Euro. The purchased notional amounts associated with these currency derivatives are ~~$151~~$144 million, ~~$117~~$131 million, ~~$38~~$54 million, ~~$24~~$21 million, ~~$23~~$19 million and ~~$18~~$17 million, respectively.

Hedges of Net Investments in Foreign Operations

We are exposed to changes in foreign currencies impacting our net investments held in foreign subsidiaries.

Cross Currency Swaps

Beginning in 2015, we entered into cross currency swaps to manage our exposure to fluctuations in the Euro-U.S. Dollar exchange rate. During the second quarter of 2019 and third quarter of 2020 we entered into additional ~~cross currency~~cross-currency swaps. The total notional amount of derivative instruments designated as net investment hedges was ~~$702~~$1,196 million and ~~$714~~$1,249 million as of March 31, ~~2020~~2021 and December 31, ~~2019,~~2020, respectively.

Foreign Currency Denominated Debt

On March 11, 2016, we issued 2.250% Senior Notes of €500 million aggregate principal amount due March 2023. We designated the entirety of the outstanding balance, or ~~$544~~$585 million and ~~$554~~$610 million as of March 31, ~~2020~~2021 and December 31, ~~2019,~~2020, respectively, net of unamortized discount, as a hedge of a net investment in certain foreign subsidiaries.

The table below presents the effect of our derivative financial instruments on the Condensed Consolidated Income Statements and Statements of Comprehensive Income:


		Three Months Ended							Three Months Ended
		March 31,							March 31,
(in millions)	(in millions)	2020		2019		(in millions)	2021		2020
Cash Flow Hedges	Cash Flow Hedges					Cash Flow Hedges
Foreign Exchange Contracts	Foreign Exchange Contracts					Foreign Exchange Contracts
Amount of (loss) recognized in OCI	Amount of (loss) recognized in OCI	$	(2)	$	(9)	Amount of (loss) recognized in OCI	$	(11)	$	(2)
Amount of loss reclassified from OCI into revenue		2		1
Amount of loss reclassified from OCI into cost of revenue		1		1
Amount of (gain) loss reclassified from OCI into revenue						Amount of (gain) loss reclassified from OCI into revenue	(2)		2
Amount of (gain) loss reclassified from OCI into cost of revenue						Amount of (gain) loss reclassified from OCI into cost of revenue	(1)		1

Net Investment Hedges	Net Investment Hedges					Net Investment Hedges
Cross Currency Swaps	Cross Currency Swaps					Cross Currency Swaps
Amount of gain recognized in OCI	Amount of gain recognized in OCI	$	45	$	7	Amount of gain recognized in OCI	$	30	$	45
Amount of income recognized in Interest Expense	Amount of income recognized in Interest Expense	4		3		Amount of income recognized in Interest Expense	5		4
Foreign Currency Denominated Debt	Foreign Currency Denominated Debt					Foreign Currency Denominated Debt
Amount of gain recognized in OCI	Amount of gain recognized in OCI	$	10	$	7	Amount of gain recognized in OCI	$	26	$	10

As of March 31, ~~2020, $2~~2021, $11 million of net losses on cash flow hedges are expected to be reclassified into earnings in the next 12 months.

As of March 31, ~~2020,~~2021, no gains or losses on the net investment hedges are expected to be reclassified into earnings over their duration.

The fair values of our derivative assets and liabilities are measured on a recurring basis using Level 2 inputs and are determined through the use of models that consider various assumptions including yield curves, time value and other measurements.

The fair values of our ~~foreign exchange~~derivative contracts currently included in our hedging program ~~designated as hedging instruments~~ were as follows:


(in millions)	(in millions)	March 31, 2020		December 31, 2019		(in millions)	March 31, 2021		December 31, 2020
Derivatives designated as hedging instruments	Derivatives designated as hedging instruments					Derivatives designated as hedging instruments
Assets
Cash Flow Hedges
Other current assets		$	6	$	—
Net Investment Hedges
Other non-current assets		$	29	$	4

Liabilities	Liabilities					Liabilities
Cash Flow Hedges	Cash Flow Hedges					Cash Flow Hedges
Other current liabilities	Other current liabilities	$	(9)	$	—	Other current liabilities	$	(11)	$	0
Net Investment Hedges	Net Investment Hedges					Net Investment Hedges
Other non-current accrued liabilities	Other non-current accrued liabilities	$	(2)	$	(24)	Other non-current accrued liabilities	$	(86)	$	(117)

The fair value of our long-term debt, due in 2023, designated as a net investment hedge was ~~$565~~$610 million and ~~$591~~$640 million as of March 31, ~~2020~~2021 and December 31, ~~2019,~~2020, respectively.

Note ~~11.~~9. Accrued and Other Current Liabilities

The components of total accrued and other current liabilities are as follows:


(in millions)	(in millions)	March 31, 2020		December 31, 2019		(in millions)	March 31, 2021		December 31, 2020
Compensation and other employee benefits		$	177	$	199
Compensation and other employee-benefits						Compensation and other employee-benefits	$	211	$	258
Customer-related liabilities	Customer-related liabilities	155		153		Customer-related liabilities	180		186
Accrued taxes	Accrued taxes	73		79		Accrued taxes	93		103
Lease liabilities	Lease liabilities	56		61		Lease liabilities	64		63
Accrued warranty costs	Accrued warranty costs	50		36		Accrued warranty costs	51		54
Other accrued liabilities	Other accrued liabilities	108		100		Other accrued liabilities	115		123
Total accrued and other current liabilities	Total accrued and other current liabilities	$	619	$	628	Total accrued and other current liabilities	$	714	$	787

Note ~~12.~~10. Credit Facilities and Debt

Total debt outstanding is summarized as follows:


(in millions)	(in millions)	March 31, 2020		December 31, 2019		(in millions)	March 31, 2021		December 31, 2020

4.875% Senior Notes due 2021 (a)	4.875% Senior Notes due 2021 (a)	$	600	$	600	4.875% Senior Notes due 2021 (a)	$	600	$	600
2.250% Senior Notes due 2023 (a)	2.250% Senior Notes due 2023 (a)	547		557		2.250% Senior Notes due 2023 (a)	587		612
3.250% Senior Notes due 2026 (a)	3.250% Senior Notes due 2026 (a)	500		500		3.250% Senior Notes due 2026 (a)	500		500
1.950% Senior Notes due 2028 (b)						1.950% Senior Notes due 2028 (b)	500		500
2.250% Senior Notes due 2031 (b)						2.250% Senior Notes due 2031 (b)	500		500
4.375% Senior Notes due 2046 (a)	4.375% Senior Notes due 2046 (a)	400		400		4.375% Senior Notes due 2046 (a)	400		400
Commercial paper		268		276

Other		191		—
Debt issuance costs and unamortized discount (b)		(16)		(17)

Debt issuance costs and unamortized discount (c)						Debt issuance costs and unamortized discount (c)	(27)		(28)

Total debt	Total debt	2,490		2,316		Total debt	3,060		3,084
Less: short-term borrowings and current maturities of long-term debt	Less: short-term borrowings and current maturities of long-term debt	459		276		Less: short-term borrowings and current maturities of long-term debt	600		600
Total long-term debt	Total long-term debt	$	2,031	$	2,040	Total long-term debt	$	2,460	$	2,484

(a)The fair value of our Senior Notes was determined using quoted prices in active markets for identical securities, which are considered Level 1 inputs. The fair value of our Senior Notes due 2021 was ~~$640~~$613 million and ~~$629~~$620 million as of March 31, ~~2020~~2021 and December 31, ~~2019,~~2020, respectively. The fair value of our Senior Notes due 2023 was ~~$565~~$610 million and ~~$591~~$640 million as of March 31, ~~2020~~2021 and December 31, ~~2019,~~2020, respectively. The fair value of our Senior Notes due 2026 was ~~$533~~$542 million and ~~$518~~$563 million as of March 31, ~~2020~~2021 and December 31, ~~2019,~~2020 respectively. The fair value of our Senior Notes due 2046 was ~~$400~~$455 million and ~~$431~~$496 million as of March 31, ~~2020~~2021 and December 31, ~~2019,~~2020, respectively.

(b)The fair value of our Senior Notes was determined using quoted prices in active markets for identical securities, which are considered Level 1 inputs. The fair value of our Senior Notes due 2028 was $500 million and $529 million as of March 31, 2021 and December 31, 2020, respectively. The fair value of our Senior Notes due 2031 was $491 million and $527 million as of March 31, 2021 and December 31, 2020, respectively.

(c)The debt issuance costs and unamortized discount are recognized as a reduction in the carrying value of the Senior Notes in the Condensed Consolidated Balance Sheets and are being amortized to interest expense in our Condensed Consolidated Income Statements over the expected remaining terms of the Senior Notes.

Senior Notes

On June 26, 2020, we issued 1.950% Senior Notes of $500 million aggregate principal amount due January 2028 (the “Senior Notes due 2028”) and 2.250% Senior Notes of $500 million aggregate principal amount due January 2031 (the “Senior Notes due 2031" and, together with the Senior Notes due 2028, the “Green Bond”).

The Green Bond includes covenants that restrict our ability, and the ability of our restricted subsidiaries, to incur debt secured by liens on certain property above a threshold, to engage in certain sale and leaseback transactions involving certain property above a threshold, and to consolidate or merge, or convey or transfer all or substantially all of our assets. We may redeem the Green Bond at any time, at our option, subject to certain conditions, at specified redemption prices, plus accrued and unpaid interest to the redemption date.

If a change of control triggering event (as defined in the applicable Green Bond indenture) occurs, we will be required to make an offer to purchase the notes at a price equal to 101% of their principal amount plus accrued and unpaid interest to the date of repurchase.

Interest on the Green Bond is payable on January 30 and July 30 of each year. As of March 31, 2021, we are in compliance with all covenants for the Green Bond.

On September 20, 2011, we issued 4.875% Senior Notes of $600 million aggregate principal amount due October 2021 (the "Senior Notes due 2021"). On March 11, 2016, we issued 2.250% Senior Notes of €500 million aggregate principal amount due March 2023 (the "Senior Notes due 2023"). On October 11, 2016, we issued 3.250% Senior Notes of $500 million aggregate principal amount due October 2026 (the “Senior Notes due 2026”) and 4.375% Senior Notes of $400 million aggregate principal amount due October 2046 (the “Senior Notes due 2046” and, together with the Senior Notes due 2021, the Senior Notes due 2023 and the Senior Notes due 2026, the “Senior Notes”).

The Senior Notes include covenants that restrict our ability, ~~subject to exceptions,~~and the ability of our restricted subsidiaries, to incur debt secured by liens ~~and~~on certain property above a threshold, to engage in certain sale and leaseback transactions ~~as well as provide for customary events~~

involving certain property above a threshold, and to consolidate or merge, or convey or transfer all or substantially all of ~~default (subject, in certain cases, to receipt of notice of default and/or customary grace and cure periods).~~our assets. We may redeem the Senior Notes, as applicable, in whole or in part, at any time at a redemption price equal to the principal amount of the Senior Notes to be redeemed, plus a make-whole premium. We may also redeem the Senior Notes in certain

other circumstances, as set forth in the applicable Senior Notes indenture.

If a change of control triggering event (as defined in the applicable Senior Notes indenture) occurs, we will be required to make an offer to purchase the Senior Notes at a price equal to 101% of their principal amount plus accrued and unpaid interest to the date of repurchase.

Interest on the Senior Notes due 2021 is payable on April 1 and October 1 of each year. Interest on the Senior Notes due 2023 is payable on March 11 of each year. Interest on the Senior Notes due 2026 and the Senior Notes due 2046 is payable on May 1 and November 1 of each ~~year beginning on May 1, 2017.~~year. As of March 31, ~~2020,~~2021, we are in compliance with all covenants for the Senior Notes.

Credit Facilities

2019 Five-Year Revolving Credit Facility

On March 5, 2019, Xylem entered into a Five-Year Revolving Credit Facility (the “2019 Credit Facility”) with Citibank, N.A., as Administrative Agent, and a syndicate of lenders. The 2019 Credit Facility provides for an aggregate principal amount of up to $800 million (available in U.S. Dollars and in Euros), with increases of up to $200 million for a maximum aggregate principal amount of $1 billion at the request of Xylem and with the consent of the institutions providing such increased commitments.

Interest on all loans under the 2019 Credit Facility is payable either quarterly or at the expiration of any LIBOR or EURIBOR interest period applicable thereto. Borrowings accrue interest at a rate equal to, at Xylem's election, a base rate or an adjusted LIBOR or EURIBOR rate plus an applicable margin. The 2019 Credit Facility includes customary provisions for implementation of replacement rates for LIBOR-based and EURIBOR-based loans. The 2019 Credit Facility also includes a pricing grid that determines the applicable margin based on Xylem's credit rating, with a further adjustment depending on Xylem's annual Sustainalytics Environmental, Social and Governance ~~score.~~("ESG") score, determined based on the methodology in effect as of March 5, 2019. Xylem will also pay quarterly fees to each lender for such lender’s commitment to lend accruing on such commitment at a rate based on our credit rating, whether such commitment is used or unused, as well as a quarterly letter of credit fee accruing on the letter of credit exposure of such lender during the preceding quarter at a rate based on the credit rating of Xylem (as adjusted for the ~~Environmental, Social and Governance~~ESG score).

The 2019 Credit Facility requires that Xylem maintain a consolidated total debt to consolidated EBITDA ratio (or maximum leverage ratio), which will be based on the last four fiscal ~~quarters,~~quarters; and in addition contains a number of customary covenants, including limitations on the incurrence of secured debt and debt of subsidiaries, liens, sale and lease-back transactions, mergers, consolidations, liquidations, dissolutions and sales of assets. The 2019 Credit Facility also contains customary events of default. Finally, Xylem has the ability to designate subsidiaries that can borrow under the 2019 Credit Facility, subject to certain requirements and conditions set forth in the 2019 Credit Facility.

On June 22, 2020, Xylem entered into Amendment No. 1 to the 2019 Credit Facility (the "Amendment") which modified the financial covenant from a test based on the maximum leverage ratio (defined as consolidated total debt to consolidated EBITDA) to a test based on the net leverage ratio (defined as consolidated total debt less unrestricted cash and cash equivalents to consolidated EBITDA). This modification is effective through the quarter ending September 30, 2021, after which the covenant will revert back to the prior maximum leverage ratio test. The Amendment also restricts stock repurchases until March 31, 2021, except for shares of common stock in an amount not to exceed the number of shares issued after the date of the Amendment, subject to customary exceptions. As of March 31, ~~2020,~~2021, the 2019 Credit Facility was undrawn and we are in compliance with all revolver covenants.

Commercial Paper

U.S. Dollar Commercial Paper Program

Our U.S. Dollar commercial paper program generally serves as a means of short-term funding with a $600 million maximum issuing balance and a combined limit of $800 million inclusive of the 2019 Credit Facility. As of March 31, ~~2020~~2021 and December 31, ~~2019,~~2020, none of the Company's $600 million U.S. Dollar commercial paper

program was outstanding. We have the ability to continue borrowing under this program going forward in future periods.

Euro Commercial Paper Program

On June 3, 2019 Xylem entered into a Euro commercial paper program with ING Bank N.V., as administrative agent, and a syndicate of dealers. The Euro commercial paper program provides for a maximum issuing balance of up to €500 million (approximately ~~$547~~$587 million) which may be denominated in a variety of currencies. The maximum issuing balance may be increased in accordance with the Dealer Agreement. As of March 31, ~~2020~~2021 and December 31, ~~2019, $268 million and $276 million~~2020, none of the Company's Euro commercial paper program was ~~outstanding, respectively, at a weighted average interest rate of (0.21)%.~~outstanding. We have the ability to continue borrowing under this program going forward in future periods.

~~Other Borrowings~~

Effective October 20, 2016, Xylem entered into an uncommitted short term facility with SEB Bank. The line of credit provides for an aggregate principal amount of up to €110 million (approximately $120 million). The full amount of €100M has been drawn on March 19, 2020 at an interest rate of 0.70% for a duration of three months with a maturity date on June 19, 2020. As of March 31, 2020 and December 31, 2019, $120 million and $0 million were outstanding under the uncommitted short term facility, respectively.

Effective November 29, 2019, Xylem entered into an uncommitted short term facility with BGL BNP Paribas Bank. The line of credit provides for an aggregate principal amount of up to €65 million (approximately $71 million). The full amount of €65M has been drawn on March 19, 2020 at an interest rate of 1.25% for a duration of three months with a maturity date in June 19, 2020. No amounts were outstanding previously under the BGL BNP Paribas Bank short term facility.

~~Subsequent Events~~

On April 25, 2020, the Company’s subsidiary, Xylem Europe GmbH (the “borrower”) entered into a 12-month €100 million (approximately $109 million) term loan facility the terms of which are set forth in a term loan agreement, among the borrower, the Company, as parent guarantor and ING Bank. The Company has entered into a parent guarantee in favor of ING Bank also dated April 25, 2020 to secure all present and future obligations of the borrower under the Term Loan Agreement. Borrowings accrue interest at a rate equal to the EURIBOR or a replacement base rate, plus an applicable margin based on Xylem's credit rating. Xylem will also pay quarterly fees whether such commitment is used or unused. To date none of the ING Bank term facility has been drawn down upon.

On April 30, 2020, the Company entered into a 12-month $50 million term loan facility the terms of which are set forth in a term loan agreement among the Company and Australia and New Zealand Banking Group Limited. Borrowings accrue interest at a rate equal to an adjusted LIBOR rate plus 1.50%.~~The full amount of $50 million has been drawn down upon on April 30, 2020.~~

Note ~~13. Postretirement~~11. Post-retirement Benefit Plans

The components of net periodic benefit cost for our defined benefit pension plans are as follows:


		Three Months Ended							Three Months Ended
		March 31,							March 31,
(in millions)	(in millions)	2020		2019		(in millions)	2021		2020
Domestic defined benefit pension plans:	Domestic defined benefit pension plans:					Domestic defined benefit pension plans:
Service cost	Service cost	$	1	$	1	Service cost	$	1	$	1
Interest cost	Interest cost	1		1		Interest cost	1		1
Expected return on plan assets	Expected return on plan assets	(2)		(2)		Expected return on plan assets	(2)		(2)

Amortization of net actuarial loss	Amortization of net actuarial loss	1		—		Amortization of net actuarial loss	1		1
Net periodic benefit cost	Net periodic benefit cost	$	1	$	—	Net periodic benefit cost	$	1	$	1
International defined benefit pension plans:	International defined benefit pension plans:					International defined benefit pension plans:
Service cost	Service cost	$	3	$	3	Service cost	$	4	$	3
Interest cost	Interest cost	4		5		Interest cost	3		4
Expected return on plan assets	Expected return on plan assets	(4)		(9)		Expected return on plan assets	(4)		(4)

Amortization of net actuarial loss	Amortization of net actuarial loss	3		2		Amortization of net actuarial loss	4		3

Net periodic benefit cost	Net periodic benefit cost	$	6	$	1	Net periodic benefit cost	$	7	$	6
Total net periodic benefit cost	Total net periodic benefit cost	$	7	$	1	Total net periodic benefit cost	$	8	$	7

The components of net periodic benefit cost other than the service cost component are included in the line item "Other non-operating ~~income,~~expense, net" in the Condensed Consolidated Income Statements.

The total net periodic benefit cost for other ~~postretirement~~post-retirement employee benefit plans was less than $1$1 million, including net credits recognized into other comprehensive income of less than $1 million, for the three months ended March 31, ~~2020~~2021 and ~~March 31, 2019, respectively.~~2020.

We contributed ~~$12~~$6 million and $5$12 million to our defined benefit plans during the three months ended March 31, ~~2020~~2021 and ~~2019,~~2020, respectively. Additional contributions ranging between approximately ~~$10~~$13 million and ~~$20~~$21 million are expected during the remainder of ~~2020.~~2021.

During Q1the first quarter of 2020, the Company purchased a bulk annuity policy with an insurance company for its largest defined benefit plan in the ~~UK,~~U.K., as a plan asset, to facilitate the termination and buy-out of the plan. The bulk annuity fully insures the benefits payable to the participants of the plan until a full buy-out of the plan can be executed, which is expected to occur in ~~2021.~~late 2021 or early 2022. Included in the Company's Q1first quarter 2020 contributions is $5 million paid to meet the shortfall between the cost of the bulk annuity policy and the plan assets. As a result of the change in assets from a mix of equities and bonds to the bulk annuity, the plan's expected rate of return on assets was reduced to 1.00% at December 31, 2019. The rate at December 31, 2018 was 7.25%. On January 27, 2020, the plan's assets of $336 million were transferred to the insurance company for the purchase of the bulk annuity.

Note ~~14.~~12. Equity

The following table shows the changes in stockholders' equity for the three months ended March 31, 2021:


	Common Stock		Capital in Excess of Par Value		Retained Earnings		Accumulated Other Comprehensive Income (Loss)		Treasury Stock		Non-Controlling Interest		Total
Balance at January 1, 2021	$	2	$	2,037	$	1,930	$	(413)	$	(588)	$	8	$	2,976
Other	—		—		—		—		—		1		1

Net income	—		—		87		—		—		—		87
Other comprehensive loss, net	—		—		��		(13)		—		0		(13)
Dividends declared ($0.28 per share)	—		—		(50)		—		—		—		(50)
Stock incentive plan activity	—		12		—		—		(7)		—		5
Repurchase of common stock	—		—		—		—		(60)		—		(60)
Balance at March 31, 2021	$	2	$	2,049	$	1,967	$	(426)	$	(655)	$	9	$	2,946

The following table shows the changes in stockholders' equity for the three months ended March 31, 2020:

Common
Stock
Capital in Excess of Par Value Retained
Earnings Accumulated Other
Comprehensive
Income (Loss) Treasury Stock Non-Controlling Interest Total
Balance at January 1, 2020 $ 2 $ 1,991 $ 1,866 $ (375) $ (527) $ 10 $ 2,967
Cumulative effect of change in accounting principle (2) (2)
Net income — — 38 — — — 38
Other comprehensive loss, net — — — (86) — (1) (87)
Dividends declared ($0.26 per share) — — (48) — — — (48)
Stock incentive plan activity — 13 — — (10) — 3
Repurchase of common stock — — — — (50) — (50)
Balance at March 31, 2020 $ 2 $ 2,004 $ 1,854 $ (461) $ (587) $ 9 $ 2,821

~~The following table shows the changes in stockholders' equity for the three months ended March 31, 2019:~~

Common
Stock
Capital in Excess of Par Value Retained
Earnings Accumulated Other
Comprehensive
Income (Loss) Treasury Stock Non-Controlling Interest Total
Balance at January 1, 2019 $ 2 $ 1,950 $ 1,639 $ (336) $ (487) $ 14 $ 2,782
Sale of business — — — — — (2) (2)
Net income — — 79 — — — 79
Other comprehensive income, net — — — 20 — — 20
Dividends declared ($0.24 per share) — — (44) — — — (44)
Stock incentive plan activity — 12 — — (14) — (2)
Repurchase of common stock — — — — (25) — (25)
Balance at March 31, 2019 $ 2 $ 1,962 $ 1,674 $ (316) $ (526) $ 12 $ 2,808


	Common Stock		Capital in Excess of Par Value		Retained Earnings		Accumulated Other Comprehensive Income (Loss)		Treasury Stock		Non-Controlling Interest		Total
Balance at January 1, 2020	$	2	$	1,991	$	1,866	$	(375)	$	(527)	$	10	$	2,967
Cumulative effect of change in accounting principle	—		—		(2)		—		—		—		(2)
Net income	—		—		38		—		—		—		38
Other comprehensive loss, net	—		—		—		(86)		—		(1)		(87)
Dividends declared ($0.26 per share)	—		—		(48)		—		—		—		(48)
Stock incentive plan activity	—		13		—		—		(10)		—		3
Repurchase of common stock	—		—		—		—		(50)		—		(50)
Balance at March 31, 2020	$	2	$	2,004	$	1,854	$	(461)	$	(587)	$	9	$	2,821

Note ~~15.~~13. Share-Based Compensation Plans

Share-based compensation expense was $8$9 million and $9$8 million during the three months ended March 31, ~~2020~~2021 and ~~2019,~~2020, respectively. The unrecognized compensation expense related to our stock options, restricted stock units and performance share units was $9$10 million, ~~$29~~$33 million and ~~$15~~$17 million, respectively, at March 31, ~~2020~~2021 and is expected to be recognized over a weighted average period of 2.3, ~~2.2~~2.4 and ~~2.4~~2.9 years, respectively. The amount of cash received from the exercise of stock options was $5$3 million and $4$5 million for the three months ended March 31, 2021 and 2020, ~~and 2019,~~ respectively.

Stock Option Grants

The following is a summary of the changes in outstanding stock options for the three months ended March 31, ~~2020~~2021:

Share units
(in thousands)
Weighted
Average
Exercise
Price / Share
Weighted Average
Remaining
Contractual
Term (Years)
Aggregate Intrinsic Value (in millions)
Outstanding at January 1, 2020 2,040 $ 48.56 6.3
Granted 334 80.66
Exercised (130) 41.18
Forfeited and expired (5) 74.37
Outstanding at March 31, 2020 2,239 $ 53.72 6.7 $ 37
Options exercisable at March 31, 2020 1,615 $ 44.45 5.7 $ 36
Vested and expected to vest as of March 31, 2020 2,146 $ 52.67 6.5 $ 36


	Share units (in thousands)	Weighted Average Exercise Price / Share		Weighted Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value (in millions)
Outstanding at January 1, 2021	1,961	$	56.66	6.4
Granted	257	102.23
Exercised	(51)	57.01
Forfeited and expired	(1)	24.60
Outstanding at March 31, 2021	2,166	$	62.04	6.6	$	92
Options exercisable at March 31, 2021	1,440	$	51.46	5.3	$	77
Vested and expected to vest as of March 31, 2021	2,073	$	60.95	6.5	$	91

The total intrinsic value of options exercised (which is the amount by which the stock price exceeded the exercise price of the options on the date of exercise) during the three months ended March 31, ~~2020~~2021 was ~~$5.6~~$2.3 million.

Stock Option Fair Value

The fair value of each option grant was estimated on the date of grant using the binomial lattice pricing model which incorporates multiple and variable assumptions over time, including assumptions such as employee exercise patterns, stock price volatility and changes in dividends. The following are weighted-average assumptions for ~~2020~~2021 grants:


Volatility	~~22.90~~ 26.30		%	%
Risk-free interest rate	~~1.15~~ 0.86		%	%
Dividend yield	~~1.29~~ 1.10		%	%
Expected term (in years)	~~5.8~~5.7
Weighted-average fair value / share	$	~~16.03~~23.20

Expected volatility is calculated based on an analysis of historic volatility measures for Xylem. We use historical data to estimate option exercise and employee termination behavior within the valuation model. Employee groups and option characteristics are considered separately for valuation purposes. The expected term represents an estimate of the period of time options are expected to remain outstanding. The risk-free rate is based on the ~~United States~~U.S. Treasury yield curve in effect at the time of option grant.

Restricted Stock Unit Grants

The following is a summary of restricted stock unit activity for the three months ended March 31, ~~2020~~2021. The fair value of the restricted share unit awards is determined using the closing price of our common stock on date of grant:


		Share units (in thousands)	Weighted Average Grant Date Fair Value /Share			Share units (in thousands)	Weighted Average Grant Date Fair Value /Share
Outstanding at January 1, 2020		512	$	68.95
Outstanding at January 1, 2021					Outstanding at January 1, 2021	537	$	74.62
Granted	Granted	219	80.66		Granted	191	102.23
Vested	Vested	(200)	64.84		Vested	(197)	76.56
Forfeited	Forfeited	(9)	71.20		Forfeited	(2)	80.74
Outstanding at March 31, 2020		522	$	75.34
Outstanding at March 31, 2021					Outstanding at March 31, 2021	529	$	83.77

ROIC Performance Share Unit Grants

The following is a summary of Return on Invested Capital ("ROIC") performance share unit grants for the three months ended March 31, ~~2020.~~2021. The fair value of the ROIC performance share units is equal to the closing share price on the date of the grant:

Share units
(in thousands)
Weighted
Average
Grant Date
Fair Value /Share
Outstanding at January 1, 2020 225 $ 64.51
Granted 67 80.66
Vested (89) 49.15
Forfeited (1) 74.17
Outstanding at March 31, 2020 202 $ 76.60


	Share units (in thousands)	Weighted Average Grant Date Fair Value /Share
Outstanding at January 1, 2021	182	$	76.12
Granted	60	102.23


Forfeited	(58)	75.10
Outstanding at March 31, 2021	184	$	84.55

TSR Performance Share Unit Grants

The following is a summary of our Total Shareholder Return ("TSR") performance share unit grants for the three months ended March 31, ~~2020:~~2021:


		Share units (in thousands)	Weighted Average Grant Date Fair Value /Share			Share units (in thousands)	Weighted Average Grant Date Fair Value /Share
Outstanding at January 1, 2020		225	$	75.80
Outstanding at January 1, 2021					Outstanding at January 1, 2021	182	$	96.98
Granted	Granted	67	105.66		Granted	60	117.56
Adjustment for Market Condition Achieved (a)	Adjustment for Market Condition Achieved (a)	35	49.15		Adjustment for Market Condition Achieved (a)	35	98.79
Vested	Vested	(124)	49.15		Vested	(93)	98.79
Forfeited		(1)	74.17
Outstanding at March 31, 2020		202	$	97.97

Outstanding at March 31, 2021					Outstanding at March 31, 2021	184	$	102.82

(a) Represents an increase in the number of original TSR performance share units awarded based on the final market condition achievement at the end of the performance period of such awards.

The fair value of TSR performance share units was calculated on the date of grant using a Monte Carlo simulation model utilizing several key assumptions, including expected Company and peer company share price volatility, correlation coefficients between peers, the risk-free rate of return, the expected dividend yield and other award design features. The following are weighted-average assumptions for ~~2020~~2021 grants:




Volatility	~~22.6~~ 33.5	%	%
Risk-free interest rate	~~1.08~~ 0.24	%	%

ESG Performance Share Unit Grants

During the first quarter of 2021, we issued a special grant of less than 0.1 million ESG performance share units. The shares will vest after 5 years based on our performance against certain of the Company's 2025 sustainability goals.

Note ~~16.~~14. Capital Stock

For the three months ended March 31, ~~2020~~2021 and March 31, ~~2019~~2020, the Company repurchased approximately 0.7 million shares of common stock for $67 million and approximately 0.8 million shares of common stock for $60 ~~million and approximately 0.5 million shares of common stock for $39~~ million, respectively. Repurchases include both share repurchase programs approved by the Board of Directors and repurchases in relation to settlement of employee tax withholding obligations due as a result of the vesting of restricted stock units. The details of repurchases by each program are as follows:

On August 24, 2015, our Board of Directors authorized the repurchase of up to $500 million in shares with no expiration date. The program's objective is to deploy our capital in a manner that benefits our shareholders and maintains our focus on growth. There were approximately ~~0.7~~0.6 million shares repurchased for ~~$50~~$60 million under ~~this~~the program for the three months ended March 31, ~~2020.~~2021. For the three months ended March 31, ~~2019,~~2020, we repurchased approximately ~~0.3~~0.7 million shares for ~~$25~~$50 million. There are up to ~~$288~~$228 million in shares that may still be purchased under this plan as of March 31, ~~2020.~~2021.

Aside from the aforementioned repurchase program, we repurchased approximately 0.1 million shares and approximately ~~0.2~~0.1 million shares for ~~approximately $10~~$7 million and ~~approximately $14~~$10 million for the three months ended March 31, ~~2020~~2021 and ~~2019,~~2020, respectively, in relation to settlement of employee tax withholding obligations due as a result of the vesting of restricted stock units.

Note ~~17.~~15. Accumulated Other Comprehensive Loss

The following table provides the components of accumulated other comprehensive loss for the three months ended March 31, ~~2020:~~2021:


(in millions)	(in millions)	Foreign Currency Translation		Postretirement Benefit Plans		Derivative Instruments		Total		(in millions)	Foreign Currency Translation		Post-retirement Benefit Plans		Derivative Instruments		Total
Balance at January 1, 2020		$	(103)	$	(269)	$	(3)	$	(375)
Balance at January 1, 2021										Balance at January 1, 2021	$	(86)	$	(330)	$	3	$	(413)
Foreign currency translation adjustment	Foreign currency translation adjustment	(77)		—		—		(77)		Foreign currency translation adjustment	10		—		—		10
Tax on foreign currency translation adjustment	Tax on foreign currency translation adjustment	(13)		—		—		(13)		Tax on foreign currency translation adjustment	(14)		—		—		(14)

Amortization of prior service cost and net actuarial loss on postretirement benefit plans into other non-operating income (expense), net		—		4		—		4
Income tax impact on amortization of postretirement benefit plan items		—		(1)		—		(1)
Amortization of prior service cost and net actuarial loss on post-retirement benefit plans into other non-operating income (expense), net										Amortization of prior service cost and net actuarial loss on post-retirement benefit plans into other non-operating income (expense), net	—		5		—		5

Income tax impact on amortization of postretirement benefit plan items										Income tax impact on amortization of postretirement benefit plan items	—		(1)		—		(1)
Unrealized loss on derivative hedge agreements	Unrealized loss on derivative hedge agreements	—		—		(2)		(2)		Unrealized loss on derivative hedge agreements	—		—		(11)		(11)
Income tax benefit on unrealized loss on derivative hedge agreements										Income tax benefit on unrealized loss on derivative hedge agreements	—		—		1		1

Reclassification of unrealized loss on foreign exchange agreements into revenue		—		—		2		2
Reclassification of unrealized loss on foreign exchange agreements into cost of revenue		—		—		1		1
Reclassification of unrealized gain on foreign exchange agreements into revenue										Reclassification of unrealized gain on foreign exchange agreements into revenue	—		—		(2)		(2)
Reclassification of unrealized gain on foreign exchange agreements into cost of revenue										Reclassification of unrealized gain on foreign exchange agreements into cost of revenue	—		—		(1)		(1)

Balance at March 31, 2020		$	(193)	$	(266)	$	(2)	$	(461)
Balance at March 31, 2021										Balance at March 31, 2021	$	(90)	$	(326)	$	(10)	$	(426)

The following table provides the components of accumulated other comprehensive loss for the three months ended March 31, ~~2019:~~2020:

(in millions) Foreign Currency Translation Postretirement Benefit Plans Derivative Instruments Total
Balance at January 1, 2019 $ (121) $ (214) $ (1) $ (336)
Foreign currency translation adjustment 29 — — 29
Tax on foreign currency translation adjustment (4) — — (4)
Amortization of prior service cost and net actuarial loss on postretirement benefit plans into other non-operating income (expense), net — 2 — 2
Income tax impact on amortization of postretirement benefit plan items — (1) — (1)
Unrealized loss on derivative hedge agreements — — (9) (9)
Income tax benefit on unrealized loss on derivative hedge agreements — — 1 1
Reclassification of unrealized loss on derivative hedge agreements into revenue — — 1 1
Reclassification of unrealized loss on foreign exchange agreements into cost of revenue — — 1 1
Balance at March 31, 2019 $ (96) $ (213) $ (7) $ (316)


(in millions)	Foreign Currency Translation		Post-retirement Benefit Plans		Derivative Instruments		Total
Balance at January 1, 2020	$	(103)	$	(269)	$	(3)	$	(375)

Foreign currency translation adjustment	(77)		—		—		(77)
Tax on foreign currency translation adjustment	(13)		—		—		(13)


Amortization of prior service cost and net actuarial loss on post-retirement benefit plans into other non-operating income (expense), net	—		4		—		4


Income tax impact on amortization of post-retirement benefit plan items	—		(1)		—		(1)
Unrealized loss on derivative hedge agreements	—		—		(2)		(2)


Reclassification of unrealized loss on foreign exchange agreements into revenue	—		—		2		2
Reclassification of unrealized loss on foreign exchange agreements into cost of revenue	—		—		1		1


Balance at March 31, 2020	$	(193)	$	(266)	$	(2)	$	(461)

Note ~~18.~~16. Commitments and Contingencies

Legal Proceedings

From time to time we are involved in legal and regulatory proceedings that are incidental to the operation of our businesses (or the business operations of previously-owned entities). These proceedings may seek remedies relating to matters including environmental, ~~matters,~~ tax, intellectual property, ~~matters,~~ acquisitions or divestitures, product liability, ~~and~~property damage, personal injury, ~~claims,~~ privacy, employment, labor and pension, ~~matters,~~ government contract issues and commercial or contractual disputes.

From time to time, claims may be asserted against Xylem alleging injury caused by any of our products resulting from asbestos exposure. We believe there are numerous legal defenses available for such claims and would defend ourselves vigorously. Pursuant to the Distribution Agreement among ITT Corporation (now ITT LLC), Exelis (acquired by Harris Corporation, now L3Harris Technologies, Inc.) and Xylem, ITT Corporation (now ITT LLC) has an obligation to indemnify, defend and hold Xylem harmless for asbestos product liability matters, including settlements, judgments, and legal defense costs associated with all pending and future claims that may arise from past sales of ITT’s legacy products. We believe ITT Corporation (now ITT LLC) remains a substantial entity with sufficient financial resources to honor its obligations to us.

See Note 6,4, "Income Taxes", of our condensed consolidated financial statements for a description of a pending tax litigation matter.

Although the ultimate outcome of any legal matter cannot be predicted with certainty, based on present information, including our assessment of the merits of the particular claims, we do not believe it is reasonably possible that any asserted or unasserted legal claims or proceedings, individually or in aggregate, will have a material adverse effect on our results of operations, or financial condition. We have estimated and accrued $3$5 million and $5$6 million as of March 31, ~~2020~~2021 and December 31, ~~2019,~~2020, respectively, for these general legal matters.

Indemnifications

As part of our 2011 spin-off from our former parent, ITT Corporation (now ITT LLC), Exelis Inc. (acquired by Harris Corporation, now L3Harris Technologies, Inc.) and Xylem will indemnify, defend and hold harmless each of the other parties with respect to such parties’ assumed or retained liabilities under the Distribution Agreement and breaches of the Distribution Agreement or related spin agreements. ~~The former parent’s~~ITT LLC's indemnification obligations include asserted and unasserted asbestos and silica liability claims that relate to the presence or alleged presence of asbestos or silica in products manufactured, repaired or sold prior to October 31, 2011, the Distribution Date, subject to limited exceptions with respect to certain employee claims, or in the structure or material of any building or facility, subject to exceptions with respect to employee claims relating to Xylem buildings or facilities. The

indemnification associated with pending and future asbestos claims does not expire. Xylem has not recorded a liability for material matters for which we expect to be indemnified by the former parent or Exelis Inc. through the Distribution Agreement and we are not aware of any claims or other circumstances that would give rise to material payments from us under such indemnifications. ~~On May 29, 2015, Harris Inc. acquired Exelis. As the parent of Exelis, Harris Inc. is responsible for Exelis’ indemnification obligations under the Distribution Agreement.~~

Guarantees

We obtain certain stand-by letters of credit, bank guarantees, surety bonds and insurance letters of credit from third-party financial institutions in the ordinary course of business when required under contracts or to satisfy ~~insurance related~~insurance-related requirements. As of March 31, ~~2020~~2021 and December 31, ~~2019,~~2020, the amount of surety bonds, bank guarantees, insurance letters of credit and stand-by letters of credit ~~and insurance letters of credit~~ was ~~$330~~$392 million and ~~$340~~$378 million, respectively.

Environmental

In the ordinary course of business, we are subject to federal, state, local, and foreign environmental laws and regulations. We are responsible, or are alleged to be responsible, for ongoing environmental investigation and remediation of sites in various countries. These sites are in various stages of investigation and/or remediation and in many of these proceedings our liability is considered de minimis. We have received notification from the ~~United States~~U.S. Environmental Protection Agency, and from similar state and foreign environmental agencies, that a number of sites formerly or currently owned and/or operated by Xylem or for which we are responsible under the Distribution Agreement, and other properties or water supplies that may be or have been impacted from those operations, contain disposed or recycled materials or wastes and require environmental investigation and/or remediation. These sites include instances where we have been identified as a potentially responsible party under federal and state environmental laws and regulations.

Accruals for environmental matters are recorded on a site-by-site basis when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated, based on current law and existing technologies. Our accrued liabilities for these environmental matters represent our best estimates related to the investigation and remediation of environmental media such as water, soil, soil vapor, air and structures, as well as related legal fees. These estimates, and related accruals, are reviewed quarterly and updated for progress of investigation and remediation efforts and changes in facts and legal circumstances. Liabilities for these

environmental expenditures are recorded on an undiscounted basis. We have estimated and accrued $3 million ~~and $3 million~~ as of March 31, ~~2020~~2021 and December 31, ~~2019, respectively,~~2020 for environmental matters.

It is difficult to estimate the final costs of investigation and remediation due to various factors, including incomplete information regarding particular sites and other potentially responsible parties, uncertainty regarding the extent of investigation or remediation and our share, if any, of liability for such conditions, the selection of alternative remedial approaches, and changes in environmental standards and regulatory requirements. We believe the total amount accrued is reasonable based on existing facts and circumstances.

Warranties

We warrant numerous products, the terms of which vary widely. In general, we warrant products against defect and specific non-performance. The table below provides ~~the~~ changes in ~~our~~the combined current and non-current product warranty ~~accrual:~~accruals over each period:


(in millions)	(in millions)	2020		2019		(in millions)	2021		2020
Warranty accrual – January 1	Warranty accrual – January 1	$	41	$	60	Warranty accrual – January 1	$	65	$	41
Net charges for product warranties in the period	Net charges for product warranties in the period	22		5		Net charges for product warranties in the period	8		22
Settlement of warranty claims	Settlement of warranty claims	(7)		(13)		Settlement of warranty claims	(9)		(7)
Foreign currency and other	Foreign currency and other	(1)		—		Foreign currency and other	(2)		(1)
Warranty accrual - March 31	Warranty accrual - March 31	$	55	$	52	Warranty accrual - March 31	$	62	$	55

Note ~~19.~~17. Segment Information

Our business has 3 reportable segments: Water Infrastructure, Applied Water and Measurement & Control Solutions. ~~When determining the reportable segments, the Company aggregated operating segments based on their similar economic and operating characteristics.~~ The Water Infrastructure segment focuses on the transportation and treatment of water, offering a range of products including water, wastewater and storm water pumps, treatment equipment, and controls and systems. The Applied Water segment serves many of the primary uses of water and focuses on the residential, commercial and industrial markets. The Applied Water segment's major products include pumps, valves, heat exchangers, controls and dispensing equipment. The Measurement & Control Solutions segment focuses on developing advanced technology solutions that enable intelligent use and conservation of critical water and energy resources as well as analytical instrumentation used in the testing of water. The Measurement & Control Solutions segment's major products include smart metering, networked communications, measurement and control technologies, critical infrastructure technologies, software and services including cloud-based analytics, remote monitoring and data management, leak detection and pressure monitoring solutions and testing equipment.

Additionally, we have Regional selling locations, which consist primarily of selling and marketing organizations and related support services, that offer products and services across our reportable segments. Corporate and other consists of corporate office expenses including compensation, benefits, occupancy, depreciation, and other administrative costs, as well as charges related to certain matters, such as environmental matters, that are managed at a corporate level and are not included in the business segments in evaluating performance or allocating resources.

The accounting policies of each segment are the same as those described in the summary of significant accounting policies (see Note 1 in the ~~2019~~2020 Annual Report). The following ~~tables contain~~table contains financial information for each reportable segment:


		Three Months Ended							Three Months Ended
		March 31,							March 31,
(in millions)	(in millions)	2020		2019		(in millions)	2021		2020
Revenue:	Revenue:					Revenue:
Water Infrastructure	Water Infrastructure	$	438	$	482	Water Infrastructure	$	509	$	438
Applied Water	Applied Water	338		379		Applied Water	393		338
Measurement & Control Solutions	Measurement & Control Solutions	347		376		Measurement & Control Solutions	354		347
Total	Total	$	1,123	$	1,237	Total	$	1,256	$	1,123
Operating Income:	Operating Income:					Operating Income:
Water Infrastructure	Water Infrastructure	$	39	$	51	Water Infrastructure	$	71	$	39
Applied Water	Applied Water	47		56		Applied Water	66		47
Measurement & Control Solutions	Measurement & Control Solutions	(12)		16		Measurement & Control Solutions	9		(12)
Corporate and other	Corporate and other	(13)		(14)		Corporate and other	(13)		(13)
Total operating income	Total operating income	$	61	$	109	Total operating income	$	133	$	61
Interest expense	Interest expense	$	16	18		Interest expense	$	21	$	16
Other non-operating (expense) income, net		(3)		2
Gain from sale of business		—		1
Other non-operating income (expense), net						Other non-operating income (expense), net	2		(3)

Income before taxes	Income before taxes	$	42	$	94	Income before taxes	$	114	$	42
Depreciation and Amortization:	Depreciation and Amortization:					Depreciation and Amortization:
Water Infrastructure	Water Infrastructure	$	15	$	15	Water Infrastructure	$	13	$	15
Applied Water	Applied Water	6		6		Applied Water	6		6
Measurement & Control Solutions	Measurement & Control Solutions	36		36		Measurement & Control Solutions	36		36
Regional selling locations (a)	Regional selling locations (a)	4		4		Regional selling locations (a)	5		4
Corporate and other	Corporate and other	3		3		Corporate and other	2		3
Total	Total	$	64	$	64	Total	$	62	$	64
Capital Expenditures:	Capital Expenditures:					Capital Expenditures:
Water Infrastructure	Water Infrastructure	$	10	$	30	Water Infrastructure	$	11	$	10
Applied Water	Applied Water	9		6		Applied Water	4		9
Measurement & Control Solutions	Measurement & Control Solutions	27		24		Measurement & Control Solutions	21		27
Regional selling locations (b)	Regional selling locations (b)	4		4		Regional selling locations (b)	3		4
Corporate and other	Corporate and other	1		5		Corporate and other	0		1
Total	Total	$	51	$	69	Total	$	39	$	51

(a)Depreciation and amortization expense incurred by the Regional selling locations was included in an overall allocation of Regional selling location costs to the segments; however, a certain portion of that expense was not specifically identified to a segment. That expense is captured in this Regional selling location line.

(b)Represents capital expenditures incurred by the Regional selling locations not allocated to the segments.


ITEM 2.			MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion should be read in conjunction with the condensed consolidated financial statements, including the notes, included elsewhere in this report on Form 10-Q (this "Report"). ~~Except as otherwise indicated or unless the context otherwise requires, "Xylem," "we," "us," "our" and the "Company" refer to Xylem Inc. and its subsidiaries.~~

This Report contains ~~information that may constitute~~ “forward-looking statements" within the meaning of Section 27A of the ~~Private~~ Securities ~~Litigation~~ Act of ~~1995. Forward-looking statements by their nature address matters that are, to different degrees, uncertain.~~1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Generally, the words “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” "contemplate," "predict," “project,” “forecast,” “likely,” “believe,” “target,” “will,” “could,” “would,” ~~“should”~~“should,” "potential," "may" and similar expressions or their negative, may, but are not necessary to, identify forward-looking statements. ~~However, the absence of these words or similar expressions does not mean that a statement is not forward-looking. These~~By their nature, forward-looking statements address uncertain matters and include any statements ~~that~~that: are not historical, ~~in nature, including any~~such as statements about ~~the capitalization of the Company, the Company’s restructuring and realignment~~our strategy, financial plans, ~~future strategic plans and other statements that describe the Company’s business strategy,~~ outlook, objectives, plans, intentions or ~~goals. All statements that~~goals; or address ~~operating~~possible or future results of operations or financial performance, ~~events or developments that we expect or anticipate will occur in the future -~~ including statements relating to orders, revenues, operating margins and earnings per share ~~growth, and~~growth.

Although we believe that the expectations reflected in any of our forward-looking statements ~~expressing general views about future operating results -~~ are ~~forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause~~reasonable, actual results tocould differ materially from those ~~expressed~~projected or ~~implied~~assumed in ~~or reasonably inferred from, such~~any of our forward-looking statements. ~~Many~~Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties, many of which are beyond our control. Additionally, many of these risks and uncertainties are, ~~currently amplified by~~ and may continue to be, amplified by ~~or in~~ the ~~future may be amplified by, the novel~~ coronavirus ~~(COVID-19)~~(“COVID-19”) pandemic.

~~Factors~~ Important factors that could cause our actual results, performance and achievements, or industry results to differ materially from ~~those anticipated include:~~estimates or projections contained in or implied by our forward-looking statements include, among others, the following: overall industry and economic conditions, including industrial, governmental and private sector spending and the strength of the residential and commercial real estate markets; geopolitical, regulatory, economic and ~~business conditions;~~other risks associated with international operations; continued uncertainty ofaround the COVID-19 pandemic’s magnitude, duration ~~geographic reach~~ and ~~impact on the global economy of the COVID-19 pandemic; the current, and uncertain future, impact of the COVID-19 pandemic~~impacts on our business, operations, growth, ~~projections,~~and financial condition, ~~operations, cash flows,~~as well as uncertainty around approved vaccines and ~~liquidity, including~~ the ~~impact~~pace of ~~adverse economic conditions caused by~~recovery when the ~~COVID-19~~ pandemic ~~on our performance or customer markets;~~subsides; actual or potential other epidemics, pandemics or global health crises; ~~geopolitical~~manufacturing and operating cost increases due to inflation, prevailing price changes, tariffs and other risks associated with our international operations, including military actions, protectionism, economic sanctions or trade barriers including tariffs and embargoes that could affect customer markets and our business, and non-compliance with laws, including foreign corrupt practice laws, data privacy, export and import laws and competition laws; potential for unexpected cancellations or delays of customer orders in our reported backlog; our exposure tofactors; fluctuations in foreign currency exchange rates; disruption, competition and pricing pressures in the markets we serve; industrial, governmental and private sector spending; the strength of housing and related markets; weather conditions; ability to retain and attract talent and key members of management; our relationship with and the performance of our supply chain including channel partners; our ability to successfully identify, complete and integrate acquisitions; our ability to borrow or to refinance our existing indebtedness and availability of liquidity sufficient to meet our needs; uncertainty from the expected discontinuance of LIBOR and transition to any other interest rate benchmark; changes in the value of goodwill or intangible assets; risks relating to product defects, product security, product liability and recalls; claims or investigations by governmental or regulatory bodies; cybersecurity ~~attacks, breaches~~incidents or other disruptions of information technology systems on which we rely, or involving our products; disruptions in operations at our facilities or that of third parties upon which we rely; availability of products, parts, electronic components and raw materials from our ~~sustainability initiatives; litigation~~supply chain; availability, regulation and interference with radio spectrum used by some of our products; our ability to retain and attract senior management and other key talent; uncertainty related to restructuring and realignment actions and related charges and savings; our ability to continue strategic investments for growth; our ability to successfully identify, execute and integrate acquisitions; risks relating to products, including defects, security, warranty and liability claims, and recalls; difficulty predicting our financial results, including uncertainties due to the nature of our short- and long-cycle businesses; volatility in our results due to weather conditions; our ability to borrow or refinance our existing indebtedness and the availability of liquidity sufficient to meet our needs; risk of future impairments to goodwill and other intangible assets; failure to comply with, or change in, laws or regulations, including those pertaining to anti-corruption, data privacy and security, export and import, competition, and the environment and climate change; changes in our effective tax rates or tax expenses; legal, governmental or regulatory claims, investigations or proceedings and associated contingent liabilities; and other factors set forth under “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, ~~2019~~2020 ("~~2019~~2020 Annual Report") and ~~with~~in subsequent filings we make with the Securities and Exchange Commission ~~("SEC"~~(“SEC”).

All forward-looking statements made herein are based on information currently available to ~~the Company~~us as of the date of this Report. ~~The Company undertakes~~We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Our quarterly financial periods end on the Saturday closest to the last day of the calendar quarter, except for the fourth quarter which ends on December 31. For ease of presentation, the reporting periods included herein are described as ending on the last day of the calendar quarter.

Overview

Xylem is a leading global water technology company. We design, manufacture and service highly engineered products and solutions ranging across a wide variety of critical applications in utility, industrial, residential and commercial building services settings. Our broad portfolio of solutions addresses customer needs across the water cycle, from the delivery, measurement and use of drinking water to the collection, test, treatment and analysis of wastewater to the return of water to the environment. Our product and service offerings are organized into three reportable segments that are aligned around the critical market applications they provide: Water Infrastructure, Applied Water and Measurement & Control Solutions.

•Water Infrastructure serves the water infrastructure sector with pump systems that transport water from aquifers, lakes, rivers and seas; with filtration, ultraviolet and ozone systems that provide treatment, making the water fit to use; and pumping solutions that move the wastewater and storm water to treatment facilities where our mixers, biological treatment, monitoring and control systems provide the primary functions in the treatment process. We also provide sales and rental of specialty dewatering pumps and related equipment and services. Additionally, our offerings use monitoring and control, smart and connected technologies to allow for remote monitoring of performance and enable products to self-optimize pump operations maximizing energy efficiency and minimizing unplanned downtime and maintenance for our customers. In the Water Infrastructure segment, we provide the majority of our sales directly to customers along with strong applications expertise, while the remaining amount is through distribution partners.

•Applied Water serves the water usage applications sector with water pressure boosting systems for heating, ventilation and air conditioning, and for fire protection systems to the residential and commercial building services markets. In addition, our pumps, heat exchangers and controls provide cooling to power plants and manufacturing facilities, circulation for food and beverage processing, as well as boosting systems for agricultural irrigation. In the Applied Water segment, we provide the majority of our sales through long-standing relationships with many of the leading independent distributors in the markets we serve, with the remainder going directly to customers.

•Measurement & Control Solutions primarily serves the utility infrastructure solutions and services sector by delivering communications, smart metering, measurement and control technologies and critical infrastructure technologies that allow customers to more effectively use their distribution networks for the delivery, monitoring and control of critical resources such as water, electricity and natural gas. We also provide analytical instrumentation used to measure and analyze water quality, flow and level in clean water, wastewater, surface water and coastal environments. Additionally, we offer software and services including cloud-based analytics, remote monitoring and data management, leak detection, condition assessment, asset management and pressure monitoring solutions. ~~We also offer smart lighting solutions that improve efficiency and public safety efforts across communities.~~ In the Measurement & Control Solutions segment, we generate our sales through a combination of long-standing relationships with leading distributors and dedicated channel partners as well as direct sales depending on the regional availability of distribution channels and the type of product.

COVID-19 Pandemic

The global outbreak of the COVID-19 disease was declared a pandemic by the World Health Organization and a national emergency by the U.S. Government in March 2020 and has created significant global volatility, uncertainty and economic disruption. The global spread of the COVID-19 pandemic has curtailed the movement of people, goods and services worldwide, including in many of the regions where we sell our products and services and conduct operations.

This section summarizes the most significant impacts related to the COVID-19 pandemic that we have experienced to date, and we have included additional details as applicable throughout other sections of this report. Many of these impacts did not begin to be felt broadly across our businesses until the latter part of the first quarter of 2020. In response to the COVID-19 pandemic, Xylem deployed a COVID-19 Response Team, responsible for Xylem's Pandemic Plan, which is designed to aid in prevention, preparedness, response and recovery at our sites. Update

Depending on the severity, magnitude and duration of the COVID-19 pandemic and its economic consequences, we anticipate that it will become more difficult to distinguish specific aspects of our operational and financial performance that are most directly related to ~~COVID-19~~the pandemic from those ~~that are~~ more broadly influenced by ongoing macroeconomic, market and industry dynamics that may be, to varying degrees, related to the pandemic and its consequences.

The COVID-19 pandemic as well as broader market dynamics have adversely affected, and are expected to continue to adversely affect, our supply chains. We have experienced shortages in the supply of components, parts and raw materials, as well as unpredictable interruptions with our external suppliers in 2021 that have led to increased logistics costs. We continue to enhance our supplier pulsing and redundancy to help mitigate these challenges. Additionally, we have in the past and may continue to take measures with respect to buffer stock or use of alternative suppliers to mitigate the impacts of freight and logistics delays and bolster our access to raw materials and components. If these shortages and interruptions are sustained, or if additional interruptions occur, they could have a negative impact on our results of operations. Our current overall operating capacity approximates normal levels globally.

~~macroeconomic, market and industry dynamics that may also be, to varying degrees, related to the COVID-19 pandemic and its consequences.~~

Public health officials have recommended, or governments have mandated, precautions to mitigate the spread of COVID-19, including stay at home or similar measures in many of the areas in which we operate. Operationally, our production facilities located in Latin America, Europe and Asia Pacific have experienced, or continue to experience reduced production levels due to such measures. Those production facilities that experienced temporarily closures have been or will be reopened in the near term.

The COVID-19 pandemic is also adversely affecting, and is expected to continue to adversely affect, our operations, supply chains and businesses. Closures and reduced facility production levels have had short term impacts to our internal supply chain. We expect to continue to experience unpredictable interruptions at our internal and external suppliers.

To date, the most significant impacts were experienced in volume reductions ranging across all segments and concentrated in Asia Pacific, particularly in China and India, and to a lesser extent, the United States and Europe.

Future demand for our products and services is uncertain as the COVID-19 pandemic has also had an adverse impact on many of the customers we serve. As such, we may experience decreased or delayed demand for our products and services, as well as changes in the payment patterns of our customers. At the end of the first quarter, total backlog increased 4.8% as compared to December 31, 2019 and cancellations were materially consistent with the prior year, with no material cancellations to date. In many cases, Xylem’s products and services are considered "essential services" under various governmental mandates, and as a result we did not experience significant issues in our ability to distribute products or services, aside from customer-driven project delays. However, because the severity, magnitude and duration of the COVID-19 pandemic and its economic consequences are uncertain, rapidly changing and difficult to predict, the pandemic’s ongoing and future impacts on our business, financial condition, results of operations, and stock price remains uncertain and difficult to predict, but we expect our results to continue to be adversely impacted beyond the quarter ending March 31, 2020.

Xylem has taken measures to protect the health and safety of our employees and work with our customers to minimize potential disruptions. We have implemented a support pay program for employees impacted by COVID-19, and an essential services premium pay program for the benefit of employees whose roles are classified as an “essential service” and, as such, are required to work either onsite at a Xylem facility or in the field supporting customers during periods of mandated stay at home or similar measures. Xylem Watermark, our corporate social responsibility program, ~~is also supporting~~continues to support our communities in addressing the challenges posed by this global pandemic through its partnership with Americares and UNICEF, as well as the ~~expansion of the~~ Partner Community Grants program and matching donations program for employees and partners, and other philanthropic commitments.

Xylem continues to focus on the health and safety of our employees, working with our customers to help them minimize potential disruptions and positively impact our communities. Our support pay program for employees impacted by COVID-19 remains in place and is evaluated for continuation, as necessary.

Many of our offices globally ~~have transitioned to~~remain in a ~~fully~~substantially remote work from home status ~~with no material disruption~~and our COVID-19 Response Team applies a set of Xylem "Return to ~~operations, financial reporting systems, internal control over financial reporting or disclosure controls~~Workplace" health and ~~procedures.~~safety guidelines for remote workers to return to our facilities.

~~We will continue to work with our customers, employees, suppliers and communities to address the impacts of COVID-19.~~ We continue to assess the evolving nature of the pandemic and its possible implications to our business, employees, supply chain, customers and ~~customers,~~communities, and to take ~~necessary~~ actions in an effort to mitigate adverse consequences.

Risk related to ~~these items~~the impact of COVID-19 as well as our supply chain are described in further detail under ~~Item 1A, "Risk~~"Item 1A. Risk Factors". in the Company's 2020 Annual Report.

Executive Summary

Xylem reported revenue for the first quarter of ~~2020~~2021 of ~~$1,123~~$1,256 million, ~~a decrease~~an increase of ~~9.2%~~11.8% compared to ~~$1,237~~$1,123 million reported in the first quarter of ~~2019.~~2020. On a constant currency basis, revenue ~~decreased~~increased by ~~$95~~$89 million, or ~~7.7%~~7.9%, driven ~~entirely~~ by organic ~~declines across all segments and~~revenue growth in all end markets. While organic revenue decline in the first quarter was anticipated, the decline was much greater than expected as our business was impacted by the global acceleration of the COVID-19 pandemic across all segments.

We generated operating income of ~~$61~~$133 million (margin of ~~5.4%~~10.6%) during the first quarter of ~~2020,~~2021, as compared to ~~$109~~$61 million (margin of ~~8.8%~~5.4%) in ~~2019.~~2020. Operating income in the first quarter of ~~2020 benefited~~2021 included an unfavorable impact from ~~decreases~~special charges incurred during the quarter of $2 million, partially offset by a decrease in restructuring and realignment costs of ~~$11 million and special charges of $4~~$1 million as compared to the first quarter of ~~2019.~~2020. Excluding the impact of these items, adjusted operating income was $143 million (adjusted margin of 11.4%) during the first quarter of 2021 as compared to $70 million (adjusted margin of 6.2%) ~~during the first quarter of 2020 as compared to $133 million (adjusted margin of 10.8%)~~ in ~~2019.~~2020. The ~~decrease~~increase in adjusted operating margin was primarily due to ~~unfavorable~~cost reductions from our productivity, restructuring and other cost saving initiatives, favorable volume, impacted ~~significantly~~ by COVID-19 ~~cost inflation, increased cost of~~recovery, and decreased quality ~~unfavorable mix and increased spending on strategic~~

~~investments.~~management costs. These impacts were partially offset by cost ~~reductions from our global procurement~~inflation, increased spending on strategic investments, unfavorable mix and ~~productivity initiatives, including restructuring savings, and price realization.~~

other lesser impacts.

Additional financial highlights for the quarter ended March 31, ~~2020~~2021 include the following:

•Orders of ~~$1,261~~$1,538 million, ~~down 4.1%~~up 22.0% from ~~$1,315~~$1,261 million in the prior year, and ~~down 2.4%~~up 18.6% on an organic basis across all ~~segments, heavily impacted by the COVID-19 pandemic.~~segments.

•Earnings per share of ~~$0.21, down 51.2%~~$0.48, up 128.6% when compared to the prior year ($~~0.23, down 55.8%~~0.56, up 143.5% on an adjusted basis).

•EBITDA margin of 17.1%, up 480 basis points compared to 12.3% in the prior year (Net Income as a percent of revenue of 6.9%, up 350 basis points compared to 3.4% in the prior year)

•Net cash flow used by operating activities of $2$26 million for the three months ended March 31, ~~2020, down $85~~2021, an increase of $24 million from cash used in the prior year. Negative free cash flow of ~~$53~~$65 million, down ~~$67~~$12 million from the prior year.

Key Performance Indicators and Non-GAAP Measures

Management reviews key performance indicators including revenue, gross margins, segment operating income and operating income margins, orders growth, working capital and backlog, among others. In addition, we consider certain non-GAAP (or "adjusted") measures to be useful to management and investors evaluating our operating performance for the periods presented, and to provide a tool for evaluating our ongoing operations, liquidity and management of assets. This information can assist investors in assessing our financial performance and measures our ability to generate capital for deployment among competing strategic alternatives and initiatives, including, but not limited to, dividends, acquisitions, share repurchases and debt repayment. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort. These adjusted metrics are consistent with how management views our business and are used to make financial, operating and planning decisions. These metrics, however, are not measures of financial performance under GAAP and should not be considered a substitute for revenue, operating income, net income, earnings per share (basic and diluted) or net cash from operating activities as determined in accordance with GAAP. We consider the following items to represent the non-GAAP measures we consider to be key performance indicators, as well as the related reconciling items to the most directly comparable measure calculated and presented in accordance with GAAP. The non-GAAP measures may not be comparable to ~~similarly titled~~similarly-titled measures reported by other ~~companies, to be key performance indicators:~~companies.

•"organic revenue" and "organic orders" defined as revenue and orders, respectively, excluding the impact of fluctuations in foreign currency translation and contributions from acquisitions and divestitures. Divestitures include sales or discontinuance of insignificant portions of our business that did not meet the criteria for classification as a discontinued operation. The period-over-period change resulting from foreign currency translation impacts is determined by translating current period and prior period activity using the same currency conversion rate.

•"constant currency" defined as financial results adjusted for foreign currency translation impacts by translating current period and prior period activity using the same currency conversion rate. This approach is used for countries whose functional currency is not the U.S. ~~dollar.~~Dollar.

•"adjusted net income" and "adjusted earnings per share" defined as net income and earnings per share, respectively, adjusted to exclude restructuring and realignment costs, special charges, gain or loss from sale of businesses and tax-related special items, as applicable. A reconciliation of adjusted net income and adjusted earnings per share is provided below.

Three Months Ended
March 31,
(In millions, except for per share data) 2020 2019
Net income & Earnings per share $ 38 $ 0.21 $ 79 $ 0.43
Restructuring and realignment, net of tax of $2 and $4 7 0.04 16 0.09
Special charges, net of tax of $0 and $0 1 — 4 0.02
Tax-related special items (4) (0.02) (4) (0.02)
Gain from sale of business, net of tax of $0 — — (1) —
Adjusted net income & Adjusted earnings per share $ 42 $ 0.23 $ 94 $ 0.52


	Three Months Ended
	March 31,
(In millions, except for per share data)	2021				2020
Net income & Earnings per share	$	87	$	0.48	$	38	$	0.21
Restructuring and realignment, net of tax of $2 and $2	6		0.03		7		0.04

Special charges, net of tax of $0 and $0	3		0.02		1		—
Tax-related special items	6		0.03		(4)		(0.02)

Adjusted net income & Adjusted earnings per share	$	102	$	0.56	$	42	$	0.23

•"adjusted operating expenses" defined as operating expenses adjusted to exclude restructuring and realignment costs and special charges.

•"adjusted operating income" defined as operating income, adjusted to exclude restructuring and realignment costs and special charges, and "adjusted operating margin" defined as adjusted operating income divided by total revenue.

•“EBITDA” defined as earnings before interest, taxes, depreciation and amortization expense "EBITDA margin" defined as EBITDA divided by total revenue, "adjusted EBITDA" reflects the adjustment to EBITDA to exclude share-based compensation charges, restructuring and realignment costs, special charges and gain or loss from sale of businesses, and "adjusted EBITDA margin" defined as adjusted EBITDA divided by total revenue.


	Three Months Ended
	March 31,
(in millions)	2021			2020
Net Income	$	87		$	38
Income tax expense	27			4
Interest expense, net	19			14
Depreciation	30			29
Amortization	32			35
EBITDA	$	195		$	120
EBITDA Margin	15.5		%	10.7		%
Share-based compensation	$	9		$	8
Restructuring and realignment	8			9

Special charges	3			1

Adjusted EBITDA	$	215		$	138
Adjusted EBITDA Margin	17.1		%	12.3		%

•“realignment costs” defined as costs not included in restructuring costs that are incurred as part of actions taken to reposition our business, including items such as professional fees, severance, relocation, travel, facility set-up and other costs.

•“special charges" defined as costs incurred by the Company, such as acquisition and integration related costs, non-cash impairment charges and ~~other special~~both operating and non-operating ~~items, such as~~adjustments for pension ~~adjustments.~~costs.

•"tax-related special items" defined as tax items, such as tax return versus tax provision adjustments, tax exam impacts, tax law change impacts, excess tax benefits/losses and other discrete tax adjustments.

•"free cash flow" defined as net cash from operating activities, as reported in the Statement of Cash Flows, less capital expenditures. Our definition of "free cash flow" does not consider certain non-discretionary cash payments, such as debt. The following table provides a reconciliation of free cash flow.

Three Months Ended
March 31,
(In millions) 2020 2019
Net cash (used) provided by operating activities $ (2) $ 83
Capital expenditures (51) (69)
Free cash flow $ (53) $ 14
Net cash used by investing activities $ (48) $ (77)
Net cash provided (used) by financing activities $ 87 $ (29)

•“EBITDA” defined as earnings before interest, taxes, depreciation and amortization expense and "Adjusted EBITDA" reflects the adjustment to EBITDA to exclude share-based compensation, restructuring and realignment costs, special charges and gain or loss from sale of businesses.

Three Months Ended
March 31,
(in millions) 2020 2019
Net Income $ 38 $ 79
Income tax expense 4 15
Interest expense (income), net 14 17
Depreciation 29 29
Amortization 35 35
EBITDA $ 120 $ 175
Share-based compensation $ 8 $ 9
Restructuring and realignment 9 20
Special charges 1 4
Gain from sale of business — (1)
Adjusted EBITDA $ 138 $ 207


	Three Months Ended
	March 31,
(In millions)	2021		2020
Net cash used by operating activities	$	(26)	$	(2)
Capital expenditures	(39)		(51)
Free cash flow	$	(65)	$	(53)
Net cash used by investing activities	$	(31)	$	(48)
Net cash (used) provided by financing activities	$	(115)	$	87

~~2020~~2021 Outlook

We ~~withdrew 2020 guidance on March 31, 2020 due~~anticipate total revenue growth in the range of 8% to ~~uncertainties caused by COVID-19. We are not prepared to reinstate full-year guidance, but are providing total~~10% in 2021, with organic revenue ~~outlook for the second quarter~~growth anticipated to be ~~down 20%~~in the range of 5% to ~~30% driven by the impact of COVID-19.~~

7%. The following is a summary of our organic revenue outlook ~~on each of our~~by end markets:

•Utilities revenue ~~decreased~~increased by approximately 5%3% organically in the first quarter driven by strength in Asia Pacific, western Europe and the Middle East, partially offset by weakness in North America. For 2021, we expect organic revenue growth in the ~~United States,~~mid to high-single-digit range with continued resilience on the wastewater side, as utilities remain focused on mission-critical applications and anticipate modest growth on a global basis through the year. Additionally, we expect that large clean water utility project deployments will be ramping up beginning in the second quarter and increasing throughout the end of the year. We expect to gain momentum behind key multi-year wins setting up healthy longer term growth and will be monitoring the global shortage of electronic components as the year progresses.

•Industrial revenue increased by approximately 14% organically in the first quarter driven by strength across all major geographic regions. For 2021, we expect organic revenue growth in the mid-single-digit range as activity across all segments rebound globally and our dewatering business in North America begins to recover as demand increases and site access restrictions continue to ease. We anticipate strong growth in the emerging markets and Europe during the first half of the year with North America lagging and tougher compares in the second half of the year.

•In the commercial markets, organic revenue growth was approximately 5% in the first quarter driven by strength in western Europe, Asia Pacific and the Middle East, partially offset by ~~strength~~weakness in the U.S. and Latin America. For 2021, we expect organic revenue growth in the low-single-digit range. We expect replacement business in the U.S. to be relatively stable during the year and anticipate continued healthy activity in Europe. ~~During 2020 we~~We expect operational spending to continue to be resilient and are seeing some areas of opportunity driven by operational pressures facing utilities. Nevertheless, utilities will be facing workforce challenges from impacts of COVID-19 on the way in which they need to operate . We also expect delays in capital projects being awarded and a potential push back in execution of current projects, but anticipate capex spending to hold up in the mid-to-longer term given the multi-year capex funding mechanisms utilities use and the governmental commitments to continued investment we're seeing in a number of our markets.

•~~Industrial revenue decreased by approximately 10% organically in the first quarter driven by weakness~~new construction activity in North America ~~Asia Pacific and western Europe. As 2020 progresses~~to be soft, however we ~~expect industrial facilities~~are optimistic that conditions will begin to limit access to sales teams and channel partners, causing slower orders and activity while non-essential work is deferred. Exposure to the down-stream impacts of a soft oil and gas market will have an effect on both our dewatering and applied water businesses potentially leading to significant demand declines. Additionally, we anticipate softnessrecover late in the ~~marine and beverage dispensing verticals driven by social distancing and mandatory lockdown constraints.~~

•In the commercial markets, organic revenue decline was approximately 11% in the first quarter driven by weakness in the emerging markets and the United States. During the short-term we expect construction site shut-downs to lead to project delays while backlog remains robust and underlying quote activity remains healthy. Although we have not seen a slowdown in project pipelines at this point in time, this is an area that we will be monitoring closely given likely recessionary effects.year.

•In the residential markets, organic revenue ~~decline~~growth was approximately ~~14%~~31% in the first quarter driven by ~~weakness~~strength in Asia Pacific, North America and western ~~Europe, the United States and Asia Pacific.~~Europe. This market is primarily driven by replacement revenue serviced through our distribution network. ~~As such,~~For 2021, we expect organic revenue growth in the high-single-digit to low-double-digit range, driven by healthy demand activity from increased residential users in the U.S. and Europe. Additionally, we anticipate ~~only emergency replacement activity as a result of social distancing requirements and expect industry softness to continue while lockdowns are~~strong demand in ~~place.~~China for secondary water supply product applications.

As result of uncertainties caused by the COVID-19 pandemic and its potential impacts on future demand, we are reevaluating aspects of our spending, including capital expenditures, strategic investments and dividends. We have identified approximately $100 million in net reductions of planned spending on a combination of operational and capital expenditures for the remainder of 2020. We will ~~also~~ continue to strategically execute restructuring and realignment actions ~~to reposition our business~~ in an effort to optimize our cost structure, ~~and~~ improve our operational efficiency and ~~effectiveness.~~effectiveness, strengthen our competitive positioning and better serve our customers. During 2021, we expect to incur between $50 million and $60 million in restructuring and realignment costs. We ~~are still assessing the amount~~expect to realize approximately $40 million of ~~any additional~~net savings in 2021, consisting of approximately $35 million of incremental net savings from restructuring and realignment actions ~~that may incurred~~initiated in 2020, and approximately $5 million of net savings from the restructuring, realignment and other structural cost actions initiated during ~~the~~this year.

Results of Operations


		Three Months Ended																		Three Months Ended
		March 31,																		March 31,
(In millions)	(In millions)	2020			2019			Change				(In millions)		2021				2020		Change
Revenue	Revenue	$	1,123		$	1,237		(9.2)	%	Revenue	$	1,256			$	1,123			11.8	%
Gross profit	Gross profit	409			474			(13.7)	%	Gross profit	490				409				19.8	%
Gross margin	Gross margin	36.4		%	38.3		%	(190)	bp	Gross margin	39.0		%		36.4		%		260	bp

Total operating expenses	Total operating expenses	348			365			(4.7)	%	Total operating expenses	357				348				2.6	%
Expense to revenue ratio	Expense to revenue ratio	31.0		%	29.5		%	150	bp	Expense to revenue ratio	28.4		%		31.0		%		(260)	bp
Restructuring and realignment costs	Restructuring and realignment costs	9			20			(55.0)	%	Restructuring and realignment costs	8				9				(11.1)	%

Special charges	Special charges	—			4			NM		Special charges	2				—				NM
Adjusted operating expenses	Adjusted operating expenses	339			341			(0.6)	%	Adjusted operating expenses	347				339				2.4	%
Adjusted operating expenses to revenue ratio	Adjusted operating expenses to revenue ratio	30.2		%	27.6		%	260	bp	Adjusted operating expenses to revenue ratio	27.6		%		30.2		%		(260)	bp
Operating income	Operating income	61			109			(44.0)	%	Operating income	133				61				118.0	%
Operating margin	Operating margin	5.4		%	8.8		%	(340)	bp	Operating margin	10.6		%		5.4		%		520	bp
Interest and other non-operating expense, net	Interest and other non-operating expense, net	19			16			18.8	%	Interest and other non-operating expense, net	19				19				—	%
Gain from sale of business		—			1			NM

Income tax expense	Income tax expense	4			15			(73.3)	%	Income tax expense	27				4				575.0	%
Tax rate	Tax rate	10.0		%	16.6		%	(660)	bp	Tax rate	23.3		%		10.0		%		1,330	bp
Net income	Net income	$	38		$	79		(51.9)	%	Net income	$	87			$	38			128.9	%

NM - Not meaningful change

Revenue

Revenue generated during the three months ended March 31, ~~2020~~2021 was ~~$1,123~~$1,256 million, reflecting ~~a decrease~~an increase of ~~$114~~$133 million, or ~~9.2%~~11.8%, compared to the same prior year period. On a constant currency basis, revenue ~~declined 7.7%~~grew 7.9% for the three months ended March 31, ~~2020.~~2021. The ~~decrease at~~increase on a constant currency ~~consisted entirely of a decline~~basis was driven by an increase in organic revenue of ~~$95~~$91 million during the quarter, reflecting ~~significantly lower demand~~strong organic growth across ~~all major geographic~~the emerging markets, particularly in China where we saw significant recovery from the impact of the COVID-19 pandemic in the prior year, and in western Europe. Strong organic growth in these regions ~~and segments largely due to COVID-19 related impacts.~~was marginally offset by organic declines in the U.S. during the quarter.

The following table illustrates the impact from organic ~~declines,~~growth, recent ~~acquisitions and~~ divestitures, and foreign currency translation in relation to revenue during the three months ended March 31, ~~2020:~~2021:


		Water Infrastructure						Applied Water						Measurement & Control Solutions					Total Xylem								Water Infrastructure				Applied Water				Measurement & Control Solutions		Total Xylem
(In millions)	(In millions)	$ Change		% Change		$ Change		% Change		$ Change		% Change			$ Change		% Change			(In millions)	$ Change		% Change		$ Change		% Change		$ Change		% Change		$ Change		% Change
2019 Revenue		$	482			$	379			$	376				$	1,237
Organic Impact		(32)		(6.6)	%	(38)		(10.0)	%	(25)		(6.6)	%		(95)		(7.7)	%
Acquisitions/(Divestitures)		—		—	%	—		—	%	—		—	%		—		—	%
2020 Revenue																				2020 Revenue	$	438			$	338			$	347			$	1,123
Organic Growth																				Organic Growth	47		10.7	%	44		13.0	%	—		—	%	91		8.1	%
Divestitures																				Divestitures	—		—	%	—		—	%	(2)		(0.6)	%	(2)		(0.2)	%
Constant Currency	Constant Currency	(32)		(6.6)	%	(38)		(10.0)	%	(25)		(6.6)	%		(95)		(7.7)	%		Constant Currency	47		10.7	%	44		13.0	%	(2)		(0.6)	%	89		7.9	%
Foreign currency translation (a)	Foreign currency translation (a)	(12)		(2.5)	%	(3)		(0.8)	%	(4)		(1.1)	%		(19)		(1.5)	%		Foreign currency translation (a)	24		5.5	%	11		3.3	%	9		2.6	%	44		3.9	%
Total change in revenue	Total change in revenue	(44)		(9.1)	%	(41)		(10.8)	%	(29)		(7.7)	%		(114)		(9.2)	%		Total change in revenue	71		16.2	%	55		16.3	%	7		2.0	%	133		11.8	%
2020 Revenue		$	438			$	338			$	347				$	1,123
2021 Revenue																				2021 Revenue	$	509			$	393			$	354			$	1,256

(a)Foreign currency translation impact for the quarter due to the ~~weakening~~strengthening in value of various currencies against the U.S. Dollar, the largest being the Euro, the ~~Australian Dollar, the Norwegian Krone, the Swedish Krona~~Chinese Yuan and the ~~Chinese Yuan.~~Australian Dollar.

Water Infrastructure

Water Infrastructure revenue ~~decreased $44~~increased $71 million, or ~~9.1%~~16.2%, for the first quarter of ~~2020 (6.6% decrease at~~2021 (10.7% increase on a constant ~~currency)~~currency basis) as compared to the prior year. Revenue ~~was negatively impacted by $12~~benefited from $24 million of foreign currency translation, with the change at constant currency coming entirely from an organic ~~decline~~growth of ~~$32~~$47 million. Organic ~~weakness~~growth for the quarter was ~~primarily~~ driven by strength in the utility end market, particularly in Asia Pacific, where China benefited from healthy order intake coming into the year as they recovered from prior year negative COVID-19 impacts, and in western Europe. Organic growth for the quarter was also driven by strength in the industrial end market, particularly across the emerging markets, which included strong growth from China COVID-19 recovery, and in ~~North America,~~western Europe. Organic growth in the industrial end market was partially offset by declines in the U.S. due to continued soft market conditions in oil and gas and in Asia Pacific, where organic growth was heavily impacted by the COVID-19 pandemic. Organic revenue decline for the quarter was also driven by weakness in the utility end market, particularly in the United States, due to softness in construction and the lapping of projects in the prior year, as well as in India due to the timing of project deployments in the prior year. We estimate that almost half of the organic revenue declines in the segment were impacted by the COVID-19 pandemic, particularly in China and India.mining.

From an application perspective, ~~the~~ organic revenue ~~decline during~~growth for the first quarter was primarily driven by our transport application. The transport application had strong revenue growth across the emerging markets, where ~~market conditions continued to soften~~we benefited from a favorable prior year comparison in ~~North America~~China and strong mining activities in Africa during the ~~dewatering applications, with oil and gas, construction and mining all down~~quarter, as well strong growth from healthy order intake in ~~the quarter. Asia Pacific~~western Europe. Organic revenue from our treatment application also contributed to the ~~organic revenue decline within the transport application, primarily~~segment's growth driven by recovery from COVID-19 volume impacts and project delays in the ~~timing of large utility project deployments~~prior year in ~~India~~China, as well as strength in Europe and the ~~negative impact of the COVID-19 pandemic throughout the region. The treatment application contributed a more modest organic revenue decline~~United States during the ~~quarter driven by the timing of filtration project deliveries in the United States.~~quarter.

Applied Water

Applied Water revenue ~~decreased $41~~increased $55 million, or ~~10.8%~~16.3%, for the first quarter of ~~2020 (10.0% decrease at~~2021 (13.0% increase on a constant ~~currency)~~currency basis) as compared to the prior year. Revenue ~~was negatively impacted by $3~~benefited from $11 million of foreign currency translation, ~~for the quarter,~~ with the change at constant currency coming entirely from an organic ~~decline~~growth of ~~$38~~$44 million. Organic ~~weakness~~growth for the quarter was driven by ~~declines~~strength in every end market and across ~~all end markets and in~~ all major geographic ~~regions. We estimate that approximately two thirds of the organic revenue declines~~regions, with particular strength in ~~the segment were driven by impacts from the COVID-19 pandemic, particularly in China~~emerging markets and ~~the United States where lockdown activities caused a slow down in the markets served.~~western Europe.

From an application perspective, ~~the~~ organic revenue ~~decline~~growth in the first quarter was led by ~~weakness~~strength in the ~~building services~~industrial water application ~~in the commercial markets~~ which was primarily driven by ~~the impact of the COVID-19 pandemic within~~market growth in the emerging markets, particularly ~~China, and~~ in ~~the United States~~Asia Pacific where the ~~timing of shipments~~industry was ~~impacted by the economic slowdown. The industrial water application also experienced a decline in organic revenue during the quarter driven by industry softening, which has been further~~more significantly impacted by the COVID-19 pandemic in the ~~emerging markets,~~prior year, and strong order intake in North America and strong backlog execution in western ~~Europe and the United States. Weakness in the~~Europe. The residential building services application revenue also had strong organic growth, primarily driven by strong second water supply business and a favorable prior year comparison in China, as markets conditions recover from the ~~residential~~COVID-19 pandemic. Strength in North America, where we benefited from healthy backlog execution coming into the year, and market growth in western Europe, also contributed ~~to the~~ organic revenue ~~decline~~growth during the quarter. The commercial building services application contributed more modest organic growth during the quarter, primarily driven by strength in western Europe and China, which was partially offset by a decline in the ~~United States and Asia Pacific.~~U.S. where the construction industry is taking longer to recover from the COVID-19 pandemic.

Measurement & Control Solutions

Measurement & Control Solutions revenue ~~decreased $29~~increased $7 million, or ~~7.7%~~2.0%, for the first quarter of ~~2020 (6.6% at~~2021 (0.6% decrease on a constant ~~currency)~~currency basis) as compared to the prior year. Revenue ~~was negatively impacted by $4~~benefited from $9 million of foreign currency translation, ~~for the quarter,~~ with the change at constant currency ~~coming entirely from an organic decline~~driven by $2 million of ~~$25 million.~~reduced revenue related to divestiture impacts. Organic ~~weakness for~~revenue remained essentially flat during the quarter ~~was driven by a decline~~as weakness in the utility end market, primarily driven by the U.S., was offset by strength in the ~~United States, Asia Pacific~~industrial end market.

In order to simplify and focus the application discussion, beginning with the first quarter of 2021, we are aggregating the test application into the water application and the ~~Middle East, partially offset by organic growth in Europe during~~software as a service and other application into the ~~quarter.~~

water and energy applications, as applicable, as both of these sub-applications provide products and services to the broader, ultimate applications of water and energy. From an application perspective, ~~the~~ organic revenue ~~decline for~~in the ~~segment was~~energy application declined during the quarter driven by ~~the water application, where we lapped strong~~slower project deployments in the ~~United States and India~~gas business, where large project deployments in the U.S. during ~~the first quarter of~~ the prior year did not repeat and we experienced project delays driven by the COVID-19 pandemic ~~which negatively impacted~~during the quarter. This decline was offset by organic revenue growth induring the ~~Middle East. Organic revenue declines within~~quarter in the water application, ~~were partially offset by organic growth in Europe during the quarter,~~ primarily driven by ~~software sales. The~~the test ~~application also~~business which experienced ~~organic revenue decline during the quarter, primarily driven by declines~~strong backlog execution in western Europe and China, ~~and North America, largely due to impacts from the~~coupled with COVID-19 ~~pandemic, including component shortages from~~recovery in China. ~~The software as a service ("SaaS") and energy applications had modest declines in revenue as compared to the prior year, primarily in the United States as we lapped a few large project deployments.~~

Orders / Backlog

An order represents a legally enforceable, written document that includes the scope of work or services to be performed or equipment to be supplied to a customer, the corresponding price and the expected delivery date for the applicable products or services to be provided. An order often takes the form of a customer purchase order or a signed quote from a Xylem business. Orders received during the first quarter of ~~2020~~2021 were ~~$1,261~~$1,538 million, ~~a decrease~~an increase of ~~$54~~$277 million, or ~~4.1%~~22.0%, over the prior year ~~(2.4% decrease at~~(18.1% increase on a constant ~~currency)~~currency basis). Order intake ~~was negatively impacted by $23~~benefited from $49 million of foreign currency translation ~~for~~during the ~~quarter, with the change at~~quarter. The order increase on a constant currency ~~coming entirely from an~~basis primarily consisted of organic ~~decline~~order growth of ~~$31 million.~~$235 million, or 18.6%.

The following table illustrates the impact from organic ~~declines,~~growth, recent ~~acquisitions and~~ divestitures, and foreign currency translation in relation to orders during the three months ended March 31, ~~2020:~~2021:


		Water Infrastructure						Applied Water						Measurement & Control Solutions							Total Xylem					Water Infrastructure				Applied Water				Measurement & Control Solutions		Total Xylem
(in millions)	(in millions)	$ Change		% Change		$ Change		% Change		$ Change		% Change			$ Change		% Change		(in millions)	$ Change		% Change		$ Change		% Change		$ Change		% Change		$ Change		% Change
2019 Orders		$	532			$	394			$	389				$	1,315
Organic Impact		(3)		(0.6)	%	(18)		(4.6)	%	(10)		(2.6)	%		(31)		(2.4)	%
Acquisitions/(Divestitures)		—		—	%	—		—	%	—		—	%		—		—	%
2020 Orders																			2020 Orders	$	514			$	372			$	375			$	1,261
Organic Growth																			Organic Growth	70		13.6	%	92		24.7	%	73		19.5	%	235		18.6	%
Divestitures																			Divestitures	—		—	%	—		—	%	(7)		(1.9)	%	(7)		(0.5)	%
Constant Currency	Constant Currency	(3)		(0.6)	%	(18)		(4.6)	%	(10)		(2.6)	%		(31)		(2.4)	%	Constant Currency	70		13.6	%	92		24.7	%	66		17.6	%	228		18.1	%
Foreign currency translation (a)	Foreign currency translation (a)	(15)		(2.8)	%	(4)		(1.0)	%	(4)		(1.0)	%		(23)		(1.7)	%	Foreign currency translation (a)	27		5.3	%	13		3.5	%	9		2.4	%	49		3.9	%
Total change in orders	Total change in orders	(18)		(3.4)	%	(22)		(5.6)	%	(14)		(3.6)	%		(54)		(4.1)	%	Total change in orders	97		18.9	%	105		28.2	%	75		20.0	%	277		22.0	%
2020 Orders		$	514			$	372			$	375				$	1,261
2021 Orders																			2021 Orders	$	611			$	477			$	450			$	1,538

(a)

Water Infrastructure

Water Infrastructure segment orders ~~decreased $18~~increased $97 million, or ~~3.4%~~18.9%, to ~~$514~~$611 million ~~(0.6% decrease at~~(13.6% increase on a constant ~~currency)~~currency basis) for the first quarter of ~~2020~~2021 as compared to the prior year. Order ~~intake during~~growth for the quarter ~~was negatively impacted by $15~~benefited from $27 million of foreign currency ~~translation, with the change at~~translation. The order increase on a constant currency ~~coming from an organic decline in orders in the transport application, which was largely offset by~~basis consisted primarily of organic order growth in the ~~treatment~~transport application. ~~Transport orders were primarily impacted~~Organic growth in the transport application was driven by ~~reduced~~strength in the emerging markets, particularly strong order ~~intake~~expansion in ~~North America as compared to~~India during the ~~prior year where we had a couple of large project orders,~~quarter, as well as healthy market ~~weakness~~conditions in Europe and North America, which were impacted by recovery from the COVID-19 pandemic impact in the ~~dewatering transport applications in~~prior year. Organic orders for the ~~United States and Europe. The~~ treatment application ~~saw organic order growth in~~also increased during the quarter, primarily driven by ~~strong order intake~~strength in ~~Europe,~~Asia Pacific, North America and Europe, which partially offset the order decline in Latin America ~~during the quarter, which was partially offset by~~from lapping of a reduction of orders in India. We believe that substantially all of the organic order decline during the quarter was due to COVID-19 impacts, partially offset by organic order growth in the treatment application.large prior year order.

Applied Water

Applied Water segment orders ~~decreased $22~~increased $105 million, or ~~5.6%~~28.2%, to ~~$372~~$477 million ~~(4.6% decrease at~~(24.7% increase on a constant ~~currency)~~currency basis) for the first quarter of ~~2020~~2021 as compared to the prior year. Order ~~intake during~~growth for the quarter ~~was negatively impacted by $4~~benefited from $13 million of foreign currency translation. The order ~~decrease~~increase on a constant currency basis was ~~primarily~~ driven by organic ~~weakness~~order growth across all end markets, primarily in the ~~United States,~~U.S., where we benefited from strong demand, amplified by early ordering being done to mitigate longer lead times, and to a ~~decrease~~lesser extent, in ~~industrial~~western Europe and the emerging markets, particularly in China whose order intake was ~~partially offset~~weakened by ~~commercial order growth during~~COVID-19 impacts in the quarter, and in Asia Pacific, which was significantly impacted by the COVID-19 pandemic during the quarter. We believe that substantially all of the organic order decline during the quarter was due to COVID-19 impacts.prior year.

Measurement & Control Solutions

Measurement & Control Solutions segment orders ~~decreased $14~~increased $75 million, or ~~3.6%~~20.0%, to ~~$375~~$450 million ~~(2.6% decrease at~~(17.6% increase on a constant ~~currency)~~currency basis) for the first quarter of ~~2020~~2021 as compared to the prior year. Order ~~intake during~~growth for the quarter ~~was negatively impacted by $4~~benefited from $9 million of foreign currency translation. The order ~~decrease~~increase on a constant currency basis included organic order growth of $73 million, or 19.5%, which was ~~driven~~partially offset by ~~an organic decline~~a $7 million reduction in orders related to divestiture impacts during the quarter. Organic order growth was led by the water application, which experienced strong order intake in the ~~SaaS application during the quarter, which was negatively impacted by the lapping of large project deployment orders in North America during the prior year. The water application contributed~~U.S. and western Europe and benefited from a ~~more modest decline in organic orders during the quarter as significant prior year project~~favorable comparison

~~deployments within the AIA platform were largely offset by water metrology orders in North America. These order declines were partially offset by organic growth~~ in the ~~quarter in the test application, primarily in Europe, and~~emerging markets, driven by COVID-19 recovery. Order intake in the energy application ~~in North America. We believe that substantially all of the organic order decline~~also grew organically during the quarter, ~~for the segment was due to COVID-19 impacts.~~primarily driven by large project deployments in North America.

Backlog

Backlog includes orders on hand as well as contractual customer agreements at the end of the period. Delivery schedules vary from customer to customer based on their requirements. Annual or multi-year contracts are subject to rescheduling and cancellation by customers due to the long-term nature of the contracts. As such, beginning total backlog, plus orders, minus revenues, will not equal ending total backlog due to contract adjustments, foreign currency fluctuations, and other factors. Typically, large projects require longer lead production cycles and deployment schedules and delays ~~can~~ occur from time to time. Total backlog was ~~$1,887~~$2,403 million at March 31, ~~2020,~~2021, an increase of ~~$54~~$516 million or ~~2.9%~~27.3%, as compared to March 31, ~~2019~~2020 backlog of ~~$1,833~~$1,887 million, and an increase of ~~$86~~$279 million or ~~4.8%~~13.1%, as compared to December 31, ~~2019~~2020 backlog of ~~$1,801 million.~~$2,124 million driven by the significant increase in orders in the quarter. We anticipate that approximately ~~56%~~54% of the backlog at March 31, ~~2020~~2021 will be recognized as revenue in the remainder of ~~2020. Cancellations in~~2021. There were no significant order cancellations during the ~~quarter were materially consistent with the prior year.~~quarter.

Gross Margin

Gross margin as a percentage of revenue ~~decreased 190~~increased 260 basis points to ~~36.4%~~39.0% for the three months ended March 31, ~~2020~~2021, as compared to ~~38.3%~~36.4% for the comparative ~~2019~~2020 period. The gross margin ~~decrease~~increase for the quarter was primarily driven by ~~unfavorable~~cost reductions from our global procurement and productivity improvement initiatives, decreased quality management costs and favorable volume, impacted by COVID-19 ~~cost inflation, increased cost of quality due to a product warranty issue in our Sensus business and unfavorable mix,~~recovery, which were partially offset by cost ~~reductions from global procurement~~inflation and ~~productivity improvement initiatives.~~other lesser impacts.

Operating Expenses

The following table presents operating expenses for the three months ended March 31, ~~2020~~2021 and ~~2019:~~2020:


		Three Months Ended																		Three Months Ended
		March 31,																		March 31,
(In millions)	(In millions)	2020			2019			Change				(In millions)		2021				2020		Change
Selling, general and administrative expenses ("SG&A")	Selling, general and administrative expenses ("SG&A")	$	297		$	303		(2.0)	%	Selling, general and administrative expenses ("SG&A")	$	301			$	297			1.3	%
SG&A as a % of revenue	SG&A as a % of revenue	26.4		%	24.5		%	190	bp	SG&A as a % of revenue	24.0		%		26.4		%		(240)	bp
Research and development expenses ("R&D")	Research and development expenses ("R&D")	49			51			(3.9)	%	Research and development expenses ("R&D")	50				49				2.0	%
R&D as a % of revenue	R&D as a % of revenue	4.4		%	4.1		%	30	bp	R&D as a % of revenue	4.0		%		4.4		%		(40)	bp
Restructuring and asset impairment charges	Restructuring and asset impairment charges	2			11			(81.8)	%	Restructuring and asset impairment charges	6				2				200.0	%

Operating expenses	Operating expenses	$	348		$	365		(4.7)	%	Operating expenses	$	357			$	348			2.6	%
Expense to revenue ratio	Expense to revenue ratio	31.0		%	29.5		%	150	bp	Expense to revenue ratio	28.4		%		31.0		%		(260)	bp

Selling, General and Administrative ("SG&A") Expenses

SG&A expenses ~~decreased~~increased by $6$4 million to $301 million, or 24.0% of revenue, in the first quarter of 2021, as compared to $297 million, or 26.4% of revenue, in the ~~first quarter of~~comparable 2020 ~~as compared to $303 million, or 24.5% of revenue, in the comparable 2019~~ period. The ~~increase~~improvement in SG&A as a percent of revenue for the quarter was primarily driven by ~~the drop in revenue, which was significantly impacted by the COVID-19 pandemic, as well as in~~ cost ~~inflation~~reductions from our productivity, restructuring and ~~additional investment in strategic growth~~other cost saving initiatives, which were partially offset by cost ~~reductions from global procurement~~inflation and ~~productivity improvement initiatives, including restructuring savings.~~additional investments in strategic growth initiatives.

Research and Development ("R&D") Expenses

R&D expense was $50 million, or 4.0% of revenue, in the first quarter of 2021, as compared to $49 million, or 4.4% of revenue, in the ~~first quarter of 2020, as compared to $51 million, or 4.1% of revenue, in the~~ comparable period of ~~2019.~~2020. The ~~increase~~decrease in R&D as a percent of revenue for the ~~period~~quarter was primarily driven by the ~~drop~~increase in revenue ~~which was significantly impacted by~~in the ~~COVID-19 pandemic.~~first quarter.

Restructuring and Asset Impairment Charges

~~Restructuring~~

During the three months ended March 31, 2021, we recognized restructuring charges of $5 million, of which $4 million relates to actions previously announced in 2020. These charges included reduction of headcount across all segments and asset impairments within our Measurement & Control Solutions segment. During the three months ended March 31, 2020, we recognized restructuring charges of $2 million. ~~We incurred~~

~~these charges primarily~~In response to the changes in business and economic conditions arising as a ~~continuation~~result of the COVID-19 pandemic, in June 2020 management committed to a restructuring plan that includes actions across our ~~efforts~~businesses and functions globally. The plan is designed to ~~reposition~~support our ~~European~~long-term financial resilience and ~~North American businesses to optimize~~simplify our ~~cost structure~~operations, strengthen our competitive positioning and ~~improve~~better serve our ~~operational efficiency and effectiveness. The charges included the reduction of headcount and consolidation of facilities within our Water Infrastructure segment.~~

The following is a roll-forward for the three months ended March 31, ~~2020~~2021 and ~~2019~~2020 of employee position eliminations associated with restructuring activities:


		2020	2019		2021	2020
Planned reductions - January 1	Planned reductions - January 1	196	69	Planned reductions - January 1	319	196
Additional planned reductions	Additional planned reductions	50	158	Additional planned reductions	57	50
Actual reductions and reversals	Actual reductions and reversals	(60)	(134)	Actual reductions and reversals	(148)	(60)
Planned reductions - March 31	Planned reductions - March 31	186	93	Planned reductions - March 31	228	186

The following table presents expected restructuring spend ~~for actions commenced as of March 31, 2020:~~in 2021 and thereafter:


(in millions)	Water Infrastructure		Applied Water		Measurement & Control Solutions		Corporate		Total
Actions Commenced in 2021:
Total expected costs	$	3	$	—	$	—	$	—	$	3
Costs incurred during Q1 2021	1		—		—		—		1


Total expected costs remaining	$	2	$	—	$	—	$	—	$	2

Actions Commenced in 2020:
Total expected costs	$	25	$	8	$	33	$	2	$	68
Costs incurred during 2020	19		4		30		—		53
Costs incurred during Q1 2021	2		1		1		—		4

Total expected costs remaining	$	4	$	3	$	2	$	2	$	11

We currently expect to incur between $35 million and ~~Measurement & Control Solutions~~$45 million in restructuring costs for the full year. These restructuring charges are primarily related to actions ~~commenced~~taken in ~~2017 consist primarily of severance charges. The Measurement & Control Solutions actions are complete and the Water Infrastructure and Applied Water actions are expected to continue through 2021.~~

~~Due~~response to the ~~impact~~changes in business and economic conditions arising as a result of the COVID-19 pandemic ~~we are reevaluating the~~as well as other efforts to optimize our cost structure, improve our operational efficiency and effectiveness, strengthen our competitive positioning and better serve our customers. We expect to realize approximately $35 million of incremental net savings in 2021 from restructuring actions ~~planned for~~initiated in 2020. As a result of all of the actions taken and expected to be taken in 2021, we anticipate approximately $4 million of total net savings to be realized during 2021.

~~Asset Impairment~~

During the first quarter of 2019 we determined that certain assets within our Measurement & Control Solutions segment, including customer relationships, were impaired. Accordingly we recognized impairment charges of $3 million. Refer to Note 9, "Goodwill and Other Intangible Assets," for additional information.

Operating Income

Operating income during the first quarter of ~~2020~~2021 was ~~$61~~$133 million, reflecting ~~a decrease~~an increase of ~~44.0%~~118.0% compared to ~~$109~~$61 million in the first quarter of ~~2019.~~2020. Operating margin was 10.6% for the first quarter of 2021 versus 5.4% for the comparable period in 2020, ~~versus 8.8% for 2019, a decrease~~an increase of ~~340~~520 basis points. Operating margin ~~benefited~~included an unfavorable impact from special charges incurred during the quarter of $2 million, partially offset by a decrease in restructuring and realignment costs of ~~$11~~$1 million ~~and special charges~~as compared to the first quarter of ~~$4 million incurred in 2019 that did not recur during~~2020. Excluding the ~~year. Excluding~~impact of these ~~restructuring and realignment costs and special charges,~~items, adjusted operating income was $143 million with an adjusted operating margin of 11.4% in the first quarter of 2021 as compared to adjusted operating income of $70 million with an adjusted operating margin of 6.2% in the first quarter of ~~2020 as compared to adjusted operating income of $133 million with an adjusted operating margin of 10.8% in the first quarter of 2019.~~2020. The ~~decrease~~increase in adjusted operating margin was primarily due to ~~unfavorable~~cost reductions from our productivity, restructuring and other cost saving initiatives, favorable volume, impacted ~~significantly~~ by COVID-19 ~~cost inflation, increased cost of~~recovery, and decreased quality ~~unfavorable mix and increased spending on strategic investments.~~management costs. These impacts were partially offset by cost ~~reductions from our global procurement~~inflation, increased spending on strategic investments, unfavorable mix and ~~productivity initiatives, including restructuring savings, and price realization.~~

other lesser impacts.

The table below provides a reconciliation of the total and each segment's operating income to adjusted operating income, and a calculation of the corresponding adjusted operating margin:


		Three Months Ended																		Three Months Ended
		March 31,																		March 31,
(In millions)	(In millions)	2020			2019			Change				(In millions)		2021				2020		Change
Water Infrastructure	Water Infrastructure									Water Infrastructure
Operating income	Operating income	$	39		$	51		(23.5)	%	Operating income	$	71			$	39			82.1	%
Operating margin	Operating margin	8.9		%	10.6		%	(170)	bp	Operating margin	13.9		%		8.9		%		500	bp
Restructuring and realignment costs	Restructuring and realignment costs	5			9			(44.4)	%	Restructuring and realignment costs	5				5				—	%

Adjusted operating income	Adjusted operating income	$	44		$	60		(26.7)	%	Adjusted operating income	$	76			$	44			72.7	%
Adjusted operating margin	Adjusted operating margin	10.0		%	12.4		%	(240)	bp	Adjusted operating margin	14.9		%		10.0		%		490	bp
Applied Water	Applied Water									Applied Water
Operating income	Operating income	$	47		$	56		(16.1)	%	Operating income	$	66			$	47			40.4	%
Operating margin	Operating margin	13.9		%	14.8		%	(90)	bp	Operating margin	16.8		%		13.9		%		290	bp
Restructuring and realignment costs	Restructuring and realignment costs	2			3			(33.3)	%	Restructuring and realignment costs	1				2				(50.0)	%

Special charges										Special charges	1				—				NM
Adjusted operating income	Adjusted operating income	$	49		$	59		(16.9)	%	Adjusted operating income	$	68			$	49			38.8	%
Adjusted operating margin	Adjusted operating margin	14.5		%	15.6		%	(110)	bp	Adjusted operating margin	17.3		%		14.5		%		280	bp
Measurement & Control Solutions	Measurement & Control Solutions									Measurement & Control Solutions
Operating (loss) income		$	(12)		$	16		(175.0)	%
Operating income (loss)										Operating income (loss)	$	9			$	(12)			175.0	%
Operating margin	Operating margin	(3.5)		%	4.3		%	(780)	bp	Operating margin	2.5		%		(3.5)		%		600	bp

Restructuring and realignment costs	Restructuring and realignment costs	2			8			(75.0)	%	Restructuring and realignment costs	2				2				—	%
Special charges		—			4			NM
Adjusted operating (loss) income		$	(10)		$	28		(135.7)	%

Adjusted operating income (loss)										Adjusted operating income (loss)	$	11			$	(10)			210.0	%
Adjusted operating margin	Adjusted operating margin	(2.9)		%	7.4		%	(1,030)	bp	Adjusted operating margin	3.1		%		(2.9)		%		600	bp
Corporate and other	Corporate and other									Corporate and other
Operating loss	Operating loss	$	(13)		$	(14)		(7.1)	%	Operating loss	$	(13)			$	(13)			—	%

Special charges										Special charges	1				—				NM
Adjusted operating loss	Adjusted operating loss	$	(13)		$	(14)		(7.1)	%	Adjusted operating loss	$	(12)			$	(13)			(7.7)	%
Total Xylem	Total Xylem									Total Xylem
Operating income	Operating income	$	61		$	109		(44.0)	%	Operating income	$	133			$	61			118.0	%
Operating margin	Operating margin	5.4		%	8.8		%	(340)	bp	Operating margin	10.6		%		5.4		%		520	bp
Restructuring and realignment costs	Restructuring and realignment costs	9			20			(55.0)	%	Restructuring and realignment costs	8				9				(11.1)	%

Special charges	Special charges	—			4			NM		Special charges	2				—				NM
Adjusted operating income	Adjusted operating income	$	70		$	133		(47.4)	%	Adjusted operating income	$	143			$	70			104.3	%
Adjusted operating margin	Adjusted operating margin	6.2		%	10.8		%	(460)	bp	Adjusted operating margin	11.4		%		6.2		%		520	bp

NM - Not meaningful percentage change

Water Infrastructure

Operating income for our Water Infrastructure segment ~~decreased $12~~increased $32 million, or ~~23.5%~~82.1%, for the first quarter of ~~2020~~2021 compared to the prior year, with operating margin also ~~decreasing~~increasing from ~~10.6%~~8.9% to ~~8.9%~~13.9%. Operating margin was impacted by $5 million in restructuring and realignment costs in both years. Excluding these restructuring and realignment costs, adjusted operating income increased $32 million, or 72.7%, with adjusted operating margin increasing from 10.0% to 14.9%. The increase in adjusted operating margin for the quarter was primarily due to cost reductions from our productivity, restructuring and other cost saving initiatives and favorable volume, impacted by COVID-19 recovery. These impacts were partially offset by cost inflation, increased spending on strategic investments, unfavorable mix, increased customer-related reserves, increased inventory management costs and other lesser impacts.

Applied Water

Operating income for our Applied Water segment increased $19 million, or 40.4%, for the first quarter of 2021 compared to the prior year, with operating margin also increasing from 13.9% to 16.8%. Operating margin benefited from a decrease in restructuring and realignment costs of $4$1 million during the quarter which was offset by $1 million of special charges incurred in ~~2020.~~2021. Excluding these ~~restructuring and realignment costs,~~items, adjusted operating income ~~decreased $16~~increased $19 million, or ~~26.7%~~38.8%, with adjusted operating margin ~~decreasing~~increasing from ~~12.4%~~14.5% to ~~10.0%~~17.3%. The ~~decrease~~increase in adjusted operating margin for the quarter was primarily due to cost ~~inflation, unfavorable~~reductions from our productivity, restructuring and other cost saving initiatives and favorable volume, impacted ~~significantly~~ by COVID-19 ~~unfavorable mix, negative currency impacts and increased spending on strategic investments.~~recovery. These impacts were partially offset by cost ~~reductions from our global procurement~~inflation, increased logistics costs, increased spending on strategic investments, unfavorable mix and ~~productivity initiatives and price realization.~~

~~Applied Water~~

Operating income for our Applied Water segment decreased $9 million, or 16.1%, for the first quarter of 2020 compared to the prior year, with operating margin also decreasing from 14.8% to 13.9%. Operating margin

benefited from a decrease in restructuring and realignment costs of $1 million in 2020. Excluding these restructuring and realignment costs, adjusted operating income decreased $10 million, or 16.9%, with adjusted operating margin decreasing from 15.6% to 14.5%. The decrease in adjusted operating margin was primarily due to cost inflation, unfavorable volume, impacted significantly by COVID-19, and increased cost of quality. These impacts were partially offset by cost reductions from our global procurement and productivity initiatives and price realization.other lesser impacts.

Measurement & Control Solutions

Operating income for our Measurement & Control Solutions segment ~~decreased $28~~increased $21 million, or 175.0%, for the first quarter of ~~2020~~2021 compared to the prior year, ~~resulting in an operating loss of $12 million,~~ with operating margin ~~also decreasing~~increasing from ~~4.3%~~(3.5)% to ~~(3.5)%~~2.5%. Operating margin ~~benefited from a decrease~~was impacted by $2 million in restructuring and realignment costs ~~of $6 million during the year and $4 million of special charges incurred during 2019 that did not recur~~ in ~~2020.~~both years. Excluding these ~~items,~~restructuring and realignment costs, adjusted operating income ~~decreased $38~~increased $21 million, or ~~135.7%~~210.0%, ~~for the quarter, resulting in an adjusted operating loss of $10 million,~~ with adjusted operating margin ~~decreasing~~increasing from ~~7.4%~~(2.9)% to ~~(2.9)%~~3.1%. The ~~decrease~~increase in adjusted operating margin for the quarter was primarily due to ~~increased~~ cost ofreductions from our restructuring, productivity and other cost saving initiatives, and decreased quality management costs, primarily due to a ~~$15 million~~specific warranty charge recorded during the ~~quarter for~~prior year that did not recur related to a firmware issue ~~in some of our meters, unfavorable volume, impacted significantly by COVID-19, cost inflation, unfavorable mix~~that was identified and ~~increased spending on strategic investments.~~addressed timely. These impacts were partially offset by cost ~~reductions from our global procurement~~inflation and ~~productivity initiatives and price realization.~~other lesser impacts.

Corporate and other

Operating loss for corporate and other ~~decreased $1~~of $13 million ~~or 7.1%, for~~during the first quarter of ~~2020~~2021 remained constant as compared to the prior ~~year.~~year, negatively impacted by $1 million of special charges incurred in 2021.

Interest Expense

Interest expense was $21 million for the three months ended March 31, 2021 and $16 million for the three months ended March 31, ~~2020 and $18 million for the three months ended March 31, 2019.~~2020. The ~~decrease~~increase in interest expense for the ~~three month~~ period ~~ended March 31, 2020~~ is primarily driven by the ~~impact~~issuance of ~~cross currency swaps~~our Green Bond during the second quarter ~~and, to a lesser extent, the favorable interest rates associated with our Euro Commercial Paper Program borrowings as compared to borrowings from U.S. Dollar Commercial Paper Program during 2019.~~of 2020. See Note 10, ~~"Derivative Financial Instruments", of our condensed consolidated financial statements for a description of our cross currency swaps. See Note 12,~~ "Credit Facilities and Debt", of our condensed consolidated financial statements for a description of our credit facilities and long-term debt and related interest.

Income Tax Expense

~~Other Comprehensive (Loss) Income~~

Other comprehensive loss was $87 million for the three months ended March 31, 2020 compared to income of $20 million for the same period in 2019. Foreign currency translation contributed unfavorable year-over-year impacts for the quarter of $107 million, driven primarily by the weakening of the Great British Pound, the Canadian Dollar, the Australian Dollar and the Chinese Yuan as compared to the U.S. Dollar in 2020 versus the strengthening of these currencies in the same prior year period. Additionally, the weakening of the Euro and the South African Rand as compared to the U.S. Dollar was greater in 2020 than the weakening of these currencies in the prior year. These unfavorable currency translation impacts were partially offset by the movement in our Euro net investment hedges during the quarter. In addition to net unfavorable foreign currency translation impacts, there was an unfavorable impact from the movement of tax on the net investment hedges as compared to the prior year of $10 million during the quarter that contributed to the loss. Partially offsetting these unfavorable drivers was the decreased loss in derivative hedge agreements during the year.

Liquidity and Capital Resources

The following table summarizes our sources and (uses) of cash:


		Three Months Ended											Three Months Ended
		March 31,											March 31,
(In millions)	(In millions)	2020		2019		Change		(In millions)	2021		2020		Change
Operating activities	Operating activities	$	(2)	$	83	$	(85)	Operating activities	$	(26)	$	(2)	$	(24)
Investing activities	Investing activities	(48)		(77)		29		Investing activities	(31)		(48)		17
Financing activities	Financing activities	87		(29)		116		Financing activities	(115)		87		(202)
Foreign exchange (a)	Foreign exchange (a)	(22)		2		(24)		Foreign exchange (a)	(15)		(22)		7
Total	Total	$	15	$	(21)	$	36	Total	$	(187)	$	15	$	(202)

(a)The impact is primarily due to the ~~weakness~~strengthening of the ~~Euro, the~~ Canadian Dollar, ~~the Chinese Yuan,~~ the Russian Ruble and various other currencies against the U.S. Dollar.

Sources and Uses of Liquidity

Operating Activities

Net cash used by operating activities was $2$26 million for the three months ended March 31, ~~2020~~2021 as compared to ~~net cash provided of $83~~$2 million in the comparable prior year period. This ~~net decrease~~increase in cash used was primarily driven by ~~the change in~~increased working capital levels to support year-over-year growth, as ~~compared to the prior year, largely resulting from the sequential use~~well as higher interest and tax payments and timing of ~~working capital following the low levels we saw at the end of 2019, and a decrease in~~compensation related payments, partially offset by increased cash ~~from~~ earnings.

Investing Activities

Cash used in investing activities was ~~$48~~$31 million for the three months ended March 31, ~~2020~~2021 as compared to ~~$77~~$48 million in the comparable prior year period. This decrease in cash used of ~~$29~~$17 million was mainly driven by lower spending on capital expenditures compared to the prior ~~year, which included the purchase of a building and new software tools, and a $5 million reduction in spending on acquisitions.~~year.

Financing Activities

Cash ~~generated~~used by financing activities was ~~$87~~$115 million for the three months ended March 31, ~~2020~~2021 as compared to cash ~~used~~generated of ~~$29~~$87 million in the comparable prior year period. This net increase in cash ~~from~~used for financing activities during the period was primarily due to higher levels of short-term debt during the first quarter of 2020 ~~partially offset by~~and an increase in share repurchase activity and dividend payments in the first quarter of ~~$21 million.~~2021.

Funding and Liquidity Strategy

Our ability to fund our capital needs depends on our ongoing ability to generate cash from operations and access to bank financing and the capital markets. As a result of uncertainties caused by the COVID-19 pandemic, we ~~are reevaluating~~continue to evaluate aspects of our spending, including capital expenditures, strategic investments and dividends. We ~~are also considering available federal, state~~will continue to evaluate aspects of our spending as the year progresses and ~~foreign tax programs related~~anticipate our capital expenditures will gradually begin to ~~timing of tax payments and deductions~~increase to ~~further manage our liquidity.~~ normal levels during the year as the markets we operate in recover.

Historically, we have generated operating cash flow sufficient to fund our primary cash needs. ~~The potentially prolonged~~We will continue to monitor the economic effects of the COVID-19 pandemic ~~may~~and its impact on the ~~Company’s~~Company's future operating cash ~~flows.~~flows going forward. If our cash flows from operations are less than we expect, we may need to incur debt or issue equity. From time to time, we may need to access the long-term and short-term capital markets to obtain financing. Our access to, and the availability of, financing on acceptable terms and conditions in the future will be impacted by many factors, including: (i) our credit ratings or absence of a credit rating, (ii) the liquidity of the overall capital markets, and (iii) the current state of the economy. There can be no assurance that such financing will be available to us on acceptable terms or that such financing will be available at all.

Our securities are rated investment grade. A significant change in credit rating could impact our ability to borrow at favorable rates. Refer to Note 10, "Credit Facilities and Debt", of our condensed consolidated financial statements for a description of limitations on obtaining additional funding.

We monitor our global funding requirements and seek to meet our liquidity needs on a ~~cost effective~~cost-effective basis. ~~The~~As of March 31, 2021, the COVID-19 pandemic has not materially impacted our borrowing costs or other costs of capital, however the future impact of the COVID-19 pandemic is uncertain and may increase our borrowing costs

and other costs of capital and otherwise adversely affect our business, results of operations, financial condition and liquidity.

We have considered the impacts of the COVID-19 pandemic on our liquidity and capital resources and do not currently expect it to impact our ability to meet future liquidity needs or continue to comply with debt covenants. Based on our current global cash positions, cash flows from operations and access to the capital markets, we believe there is sufficient liquidity to meet our funding ~~requirements.~~requirements and service debt and other obligations in both the U.S. and outside of the U.S. during the year. In addition, we believe our existing committed credit

facilities and access to the public debt markets would provide further liquidity if required. Currently, we have available liquidity of approximately ~~$1.7~~$2.5 billion, consisting of $1.7 billion of cash and $800 million of available credit ~~facilities, including term loan~~ facilities as disclosed in Note ~~12,~~10, "Credit Facilities and Debt", of our condensed consolidated financial statements. Our debt repayment obligations in ~~2020~~2021 consist of ~~$268~~$600 million in ~~outstanding commercial paper and $191 million~~Senior Notes, which we expect to pay out of ~~other borrowings.~~cash. Our next ~~long term~~long-term debt maturity is ~~October 2021.~~March 2023.

Risk related to these items are described ~~below and~~in our risk factor disclosures referenced under ~~Item 1A, "Risk~~“Item 1A. Risk Factors". in our 2020 Annual Report.

Credit Facilities & Long-Term Contractual Commitments

See Note ~~12,~~10, "Credit Facilities and Debt", of our condensed consolidated financial statements for a description of our credit facilities and long-term debt.

~~Non-United States~~Non-U.S. Operations

We generated approximately ~~50%~~56% and ~~51%~~50% of our revenue from ~~non-United States~~non-U.S. operations for the three months ended March 31, ~~2020~~2021 and ~~2019, respectively.~~2020. As we continue to grow our operations in the emerging markets and elsewhere outside of the ~~United States,~~U.S., we expect to continue to generate significant revenue from ~~non-United States~~non-U.S. operations and expect that a substantial portion of our cash will be predominately held by our foreign subsidiaries. We expect to manage our worldwide cash requirements considering available funds among the many subsidiaries through which we conduct business and the cost effectiveness with which those funds can be accessed. We may transfer cash from certain international subsidiaries to the ~~United States~~U.S. and other international subsidiaries when we believe it is ~~cost effective~~cost-effective to do so. We continually review our domestic and foreign cash profile, expected future cash generation and investment opportunities, and reassess whether there is a need to repatriate funds held internationally to support our ~~United States~~U.S. operations. As of March 31, ~~2020,~~2021, we have provided a deferred tax liability of $8$6 million for net foreign withholding taxes and state income taxes on ~~$505~~$356 million of earnings expected to be repatriated to the ~~United States~~U.S. parent as deemed necessary in the future.

Critical Accounting Estimates

Our discussion and analysis of our results of operations and capital resources are based on our condensed consolidated financial statements, which have been prepared in conformity with GAAP. The preparation of these condensed consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses and the disclosure of contingent assets and liabilities. We believe the most complex and sensitive judgments, because of their significance to the condensed consolidated financial statements, result primarily from the need to make estimates about the effects of matters that are inherently uncertain, particularly at this time and moving forward given the uncertainty around the magnitude and duration of the COVID-19 pandemic. Management’s Discussion and Analysis of Financial Condition and Results of Operations in the ~~2019~~2020 Annual Report describes the critical accounting estimates used in preparation of the condensed consolidated financial statements. Actual results in these areas could differ from management’s estimates. Other than as discussed below, there have been no significant changes in the information concerning our critical accounting estimates as stated in our ~~2019~~2020 Annual Report.

~~The carrying value~~In the third quarter of ~~our~~2020, management updated forecasts of future cash flows for the Advanced Infrastructure Analytics ~~(“AIA”~~("AIA") businesses, which reflected significant negative volume impacts from the COVID-19 pandemic, primarily on our assessment services business. Our ongoing investment in the AIA businesses also continues to impact near-term profitability. Based on these factors we determined that there were indicators that the AIA reporting unit’s goodwill ~~reporting unit is $169 million~~may be impaired, and accordingly, we performed an interim goodwill impairment test as of ~~March 31,~~July 1, 2020. ~~During~~The results of the ~~fourth quarter of 2019 we completed our annual goodwill assessment. Our 2019~~ impairment ~~analysis indicated~~test showed that the fair value of the AIA reporting unit ~~exceeded its~~was lower than the carrying value, ~~by less than 20%. We used~~resulting in a $58 million goodwill impairment charge. As of March 31, 2021 the ~~income approach to determine the fair value of~~remaining goodwill balance in our ~~goodwill reporting units. Under the income approach, the fair value of the reporting units was based on the present value of the estimated cash flows that the~~AIA reporting unit is expected to generate over its remaining life. Cash flow projections were based on management’s estimates of revenue growth rates and operating margins, taking into consideration industry and market conditions. The discount rateafter recording the goodwill impairment charge was ~~based on the weighted average cost of capital appropriate for the reporting unit.~~$112 million.

~~Given the~~

The uncertainty of the future impact of the COVID-19 pandemic may also contribute to further deterioration of our future cash ~~flows may lead to a charge to earnings. We will continue to evaluate~~flows. If we do not achieve our forecasts, it is possible that the goodwill ~~on an annual basis as~~ of the ~~beginning of our fourth quarter~~AIA reporting unit could be deemed to be impaired again in a future period. The risks and ~~whenever events and changes in circumstances indicate there may be a potential impairment.~~

~~See Item 1A, "Risk Factors" for a discussion of the~~ potential impacts of COVID-19 on the fair value of our ~~assets.~~

~~New Accounting Pronouncements~~

~~See Note 2, "Recently Issued Accounting Pronouncements", to~~assets are included in our risk factor disclosures referenced under “Item 1A. Risk Factors" in the ~~condensed consolidated financial statements for a complete discussion of recent accounting pronouncements.~~Company's 2020 Annual Report.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

There has been no ~~other~~ material change in the information concerning market risk as stated in our ~~2019~~2020 Annual Report.

ITEM 4. CONTROLS AND PROCEDURES

Our management, with the participation of the Chief Executive Officer and Chief Financial Officer of the Company, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) as of the end of the period covered by this quarterly report. Any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. Based on such evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of the period covered by this report, the Company’s disclosure controls and procedures were effective at the reasonable assurance level.

There have been no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) under the 1934 Act) during the fiscal quarter covered by this quarterly report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

4443

PART II

ITEM 1. LEGAL PROCEEDINGS

From time to time we are involved in legal and regulatory proceedings that are incidental to the operation of our businesses (or the business operations of ~~previously owned~~previously-owned entities). These proceedings may seek remedies relating to matters including environmental, ~~matters,~~ tax, intellectual property, ~~matters,~~ acquisitions or divestitures, product liability, ~~and~~property damage, personal injury, ~~claims,~~ privacy, employment, labor and pension, ~~matters,~~ government contract issues and commercial or contractual disputes. See Note ~~18,~~16, "Commitments and Contingencies", to the condensed consolidated financial statements for further information and any updates.

ITEM 1A. RISK FACTORS

~~Information regarding our~~There have been no material changes from the risk factors ~~appears~~previously disclosed in ~~Item~~"Item 1A. Risk Factors" of our ~~Annual Report on Form 10-K for the fiscal year ended December 31, 2019 filed with the SEC on February 28,~~ 2020 ("Annual Report"). These risk factors describe some of the assumptions, risks, uncertainties and other factors that could materially and adversely affect our business, financial condition or operating results. In addition, the following risk factor represents a material change in our risk factors from those disclosed in Item 1A. of our Annual Report.

Our business, results of operations and stock price have been adversely impacted by the coronavirus disease 2019 (COVID-19), and we are unable to predict the full extent to which COVID-19 may adversely impact our business, operations, financial condition, results of operations, and stock price in the future.

The coronavirus disease 2019 (COVID-19) pandemic has created significant global volatility, uncertainty and economic disruption. The global spread of the COVID-19 pandemic has curtailed the movement of people, goods and services worldwide, including in many of the regions where we sell our products and services and conduct operations. Public health officials have recommended, or governments have mandated, precautions to mitigate the spread of COVID-19, including stay at home or similar measures in many of the areas in which we operate. This has resulted in temporary production impacts at several of our facilities over the past several months, and also curtailed the business and operations of some of our customers and suppliers.

The COVID-19 pandemic is adversely affecting, and is expected to continue to adversely affect, our operations, supply chains and businesses, and we have experienced, and expect to continue to experience, unpredictable interruptions at our suppliers and reductions in demand for certain of our products and services as the COVID-19 pandemic has also had an adverse impact on many of the customers we serve. Because the severity, magnitude and duration of the COVID-19 pandemic and its economic consequences are uncertain, rapidly changing and difficult to predict, the pandemic’s impact on our business, operations, financial condition and results, and stock price remains uncertain and difficult to predict, but we expect our results to be adversely impacted beyond the quarter ending March 31, 2020.

The extent to which the COVID-19 pandemic impacts our business, operations, financial condition and results, and stock price will depend on numerous evolving factors that remain uncertain, many of which are not within our control or which we may not effectively respond to, including: the duration and scope of the pandemic; governmental, business and individuals’ mandates, actions and protocols that have been and continue to be taken in response to the pandemic; shortage of labor due to stay at home mandates, quarantines or prolonged illness of our employees or that of our customers or suppliers; the impact of the pandemic on economic activity and actions taken in response; the effect on our customers’ demand for our products and services, including slowed decision-making, delay or cancellation of orders or planned projects, or termination of existing agreements; the ability of our suppliers to supply us with products, parts and raw materials, including the ability of our suppliers to meet logistics or delivery requirements; our ability to sell and provide our products and services, including as a result of travel restrictions and people working from home; the ability of our customers to pay for our products and services; any closures of our and our customers’ facilities or suspension of operations; commodity cost volatilities; and the pace of recovery when the COVID-19 pandemic subsides, as well as response to potential recurrence.

Additionally, concerns over the economic impact of COVID-19 have caused extreme volatility in financial and other capital markets which has, and may continue to, adversely impact our stock price. The financial and capital market volatility may also increase our cost of capital or may limit the availability of additional capital or make it more difficult to secure, possibly only on terms less favorable to us. A sustained downturn may impact our liquidity position, including our ability to continue to pay dividends. A sustained downturn in the financial markets and asset

values may also result in the carrying value of our goodwill or other intangible assets exceeding their fair value, which may require us to recognize an impairment to those assets. The effects of the COVID-19 pandemic, including remote working arrangements for employees, may also impact our financial reporting systems and internal control over financial reporting.

Further, the COVID-19 pandemic, and the volatile regional and global economic conditions stemming from the pandemic, could also precipitate or aggravate the other risk factors that we identify in our 2019 Annual Report on Form 10-K, which could materially adversely affect our business, financial condition, results of operations and/or stock price. Additionally, the COVID-19 pandemic may also affect our operating and financial results in a manner that is not presently known to us or that we currently do not consider to present significant risks to our operations.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

The following table presents information with respect to purchases of the Company's common stock by the Company during the three months ended March 31, ~~2020:~~2021:

(IN MILLIONS, EXCEPT PER SHARE AMOUNTS)
PERIOD
TOTAL NUMBER OF SHARES PURCHASED AVERAGE PRICE PAID PER SHARE (a) TOTAL NUMBER OF SHARES PURCHASED AS PART OF PUBLICLY ANNOUNCED PLANS OR PROGRAMS (b) APPROXIMATE DOLLAR VALUE OF SHARES THAT MAY YET BE PURCHASED UNDER THE PLANS OR PROGRAMS (b)
1/1/20 - 1/31/20 — — — $338
2/1/20 - 2/29/20 — — — $338
3/1/20 - 3/31/20 0.7 77.06 0.7 $288


(IN MILLIONS, EXCEPT PER SHARE AMOUNTS) PERIOD	TOTAL NUMBER OF SHARES PURCHASED	AVERAGE PRICE PAID PER SHARE (a)	TOTAL NUMBER OF SHARES PURCHASED AS PART OF PUBLICLY ANNOUNCED PLANS OR PROGRAMS (b)	APPROXIMATE DOLLAR VALUE OF SHARES THAT MAY YET BE PURCHASED UNDER THE PLANS OR PROGRAMS (b)
1/1/21 - 1/31/21	—	—	—	$288
2/1/21 - 2/28/21	0.3	100.07	0.3	$258
3/1/21 - 3/31/21	0.3	101.07	0.3	$228

This table does not include shares tendered to satisfy the exercise price in connection with cashless exercises of employee stock options or shares tendered to satisfy tax withholding obligations in connection with employee equity awards.

(a)Average price paid per share is calculated on a settlement basis.

(b)On August 24, 2015, our Board of Directors authorized the repurchase of up to $500 million in shares with no expiration date. The program's objective is to deploy our capital in a manner that benefits our shareholders and maintains our focus on growth. For the three months ended March 31, ~~2020,~~2021, we repurchased ~~0.7~~0.6 million shares for ~~$50~~$60 million. There are up to ~~$288~~$228 million in shares that may still be purchased under this plan as of March 31, ~~2020.~~2021.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

None.

ITEM 6. EXHIBITS

See the Exhibit Index for a list of exhibits filed as part of this report and incorporated herein by reference.

4644

XYLEM INC.

EXHIBIT INDEX


Exhibit Number		Description	Location

3.1		Fourth Amended and Restated Articles of Incorporation of Xylem Inc.	Incorporated by reference to Exhibit 3.1 of Xylem Inc.’s Form 8-K filed on May 15, 2017 (CIK No. 1524472, File No. 1-35229).

3.2		Fourth Amended and Restated By-laws of Xylem Inc.	Incorporated by reference to Exhibit 3.2 of Xylem Inc.’s Form 8-K filed on May 15, 2017 (CIK No. 1524472, File No. 1-35229).

10.1	#	Letter Agreement between Xylem Inc. and Matthew Pine.	Filed herewith.

10.2	#	Individual Employment Contract between Xylem Europe GmbH and Hayati Yarkadas.	Filed herewith.

10.3	#	Form of Xylem 2011 Omnibus Incentive Plan Non-Qualified Stock Option Award Agreement (2021).	Filed herewith.

10.4	#	Form of 2011 Omnibus Incentive Plan Performance Share Unit Agreement (2021).	Filed herewith.

10.5	#	Form of 2011 Omnibus Incentive Plan Restricted Stock Unit Agreement (2021).	Filed herewith.

10.6	#	Form of 2011 Omnibus Incentive Plan ESG Performance Share Unit Agreement (2021).	Filed herewith.

31.1		Certification pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002	Filed herewith.

31.2		Certification pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002	Filed herewith.

32.1		Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002	This Exhibit is intended to be furnished in accordance with Regulation S-K Item 601(b) (32) (ii) and shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934 or incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference.

32.2		Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002	This Exhibit is intended to be furnished in accordance with Regulation S-K Item 601(b) (32) (ii) and shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934 or incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference.

~~10.35~~	~~Term Loan Agreement, dated as of April 25, 2020 among Xylem Europe GmbH, as borrower, Xylem Inc., as parent guarantor and ING Bank, as lender (including Form of Parent Guarantee)~~	~~Filed herewith.~~

~~10.36~~Exhibit Number			~~Term Loan Agreement, dated April 30, 2020 among Xylem Inc., as borrower, and Australia and New Zealand Banking Group Limited, as lender~~Description	~~Filed herewith.~~Location

101.0			The following materials from Xylem Inc.’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, ~~2020,~~2021, formatted in Inline Extensible Business Reporting Language (Inline XBRL): (i) Condensed Consolidated Income Statements, (ii) Condensed Consolidated Statements of Comprehensive Income, (iii) Condensed Consolidated Balance Sheets, (iv) Condensed Consolidated Statements of Cash Flows and (v) Notes to Condensed Consolidated Financial Statements	The instance document does not appear in the interactive data file because its XBRL tags are embedded within the Inline XBRL document.
104.0			The cover page from Xylem Inc.'s Quarterly Report on Form 10-Q for the period ended March 31, ~~2020~~2021 formatted in Inline XBRL and contained in Exhibit 101.0.

#Management contract or compensatory plan or arrangement

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


						XYLEM INC.
						(Registrant)

						/s/ Geri McShane
						Geri McShane
						Vice President, Controller and Chief Accounting Officer

May ~~5, 2020~~4, 2021

4847